Pasar al contenido principal

ESTRATEGIA QUIMIOGENETICA PARA LA ELUCIDACION DEL SUBSTRATO NEUROBIOLOGICO DE LA PERDIDA DE CONTROL DE LA INGESTA ALIMENTARIA

SAF2017-84060-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 59
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

  • Navarro Romero, Alba, 1990-
  • Galera López, Lorena, 1993-
  • Ortiz Romero, Paula, 1994-
  • Llorente-Ovejero, Alberto
  • Los Reyes-Ramírez, Lucía de
  • Bengoetxea de Tena, Iker
  • Garcia-Elias Heras, Anna
  • Mas Stachurska, Aleksandra
  • Reixachs i Solé, Marina
  • Pastor, Antonio
  • Torre Fornell, Rafael de la
  • Maldonado, Rafael, 1961-
  • Benito Villabriga, Begoña
  • Eyras Jiménez, Eduardo
  • Rodríguez-Puertas, Rafael
  • Campuzano Uceda, María Victoria
  • Ozaita Mintegui, Andrés, 1969-
Williams-Beuren syndrome (WBS) is a rare genetic multisystemic disorder characterized by mild-to-moderate intellectual disability and hypersocial phenotype, while the most life-threatening features are cardiovascular abnormalities. Nowadays, there are no pharmacological treatments to directly ameliorate the main traits of WBS. The endocannabinoid system (ECS), given its relevance for both cognitive and cardiovascular function, could be a potential druggable target in this syndrome. We analyzed the components of the ECS in the complete deletion (CD) mouse model of WBS and assessed the impact of its pharmacological modulation in key phenotypes relevant for WBS. CD mice showed the characteristic hypersociable phenotype with no preference for social novelty and poor short-term object-recognition performance. Brain cannabinoid type-1 receptor (CB1R) in CD male mice showed alterations in density and coupling with no detectable change in main endocannabinoids. Endocannabinoid signaling modulation with subchronic (10 days) JZL184, a selective inhibitor of monoacylglycerol lipase, specifically normalized the social and cognitive phenotype of CD mice. Notably, JZL184 treatment improved cardiovascular function and restored gene expression patterns in cardiac tissue. These results reveal the modulation of the ECS as a promising novel therapeutic approach to improve key phenotypic alterations in WBS., This study was supported by Ministerio de Economía, Innovación y Competitividad (MINECO), Spain #RTI2018-099282-B-I00B to A.O., #SAF2017-84060-R to R.M.; Generalitat de Catalunya, Spain (2017SGR-669 to R.M.); Ministerio de Ciencia e Innovación (SAF2016-78508-R; AEI/MINEICO/FEDER, UE) to VC. Basque Government IT1454-22 to the 'Neurochemistry and Neurodegeneration' consolidated research group to R R-P. Instituto de Salud Carlos III (PI20/00153, co-funded by the European Union [ERDF 'A way to make Europe']) to R R-P. ICREA (Institució Catalana de Recerca i Estudis Avançats, Spain) Academia to A.O. and R.M. Grant 'Unidad de Excelencia María de Maeztu', funded by the MINECO (#MDM-2014-0370); IPEP MdM 2017 to A.O. and E.E. FEDER, European Commission funding is also acknowledged.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Julià Hernández, Marina
  • Gagliano, Humberto
  • Andero, Raül
  • Armario García, Antonio
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Δ9-tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. The interaction between genetic or environmental events and cannabinoid exposure in the adolescent period can also contribute to exacerbate behavioural deficits in adulthood. Here we investigate the effects of THC treatment as well as the consequences of concomitant THC and stress exposure during adolescence in the extinction of fear memory in adult mice. Adolescent mice treated with THC and exposed to stress exhibit impaired cued fear extinction in adulthood. However, no effect was observed in animals exposed to these two factors separately. Notably, resistance to fear extinction was associated with decreased neuronal activity in the basolateral amygdala (BLA) and the infralimbic prefrontal cortex, suggesting a long-term dysregulation of the fear circuit. These changes in neuronal activation were paralleled with structural plasticity alterations. Indeed, an increase of immature dendritic spines in pyramidal neurons of the BLA was revealed in mice simultaneously exposed to THC and stress. Corticosterone levels were also enhanced after the cued fear conditioning session in the same experimental group. These results show that an interaction between cannabis exposure and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the "Generalitat de Catalunya-AGAUR" (#2014-SGR-1547), ICREA-Acadèmia(2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM, NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MINECOSAF2016-76565-R and FEDER funds to RA, and “Ministerio de Economía y Competitividad” (SAF2014-53876R) and “Generalitat de Catalunya” (SGR 2014-1020) to AA
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Protein kinase C-gamma knockout mice show impaired hippocampal short-term memory while preserved long-term memory

  • Gomis González, Maria, 1988-
  • Galera López, Lorena, 1993-
  • Ten-Blanco, Marc
  • Busquets Garcia, Arnau, 1985-
  • Cox, Thomas
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
The brain encodes, stores, and retrieves relevant information in the form of memories that are classified as short-term (STM) and long-term memories (LTM) depending on the interval between acquisition and retrieval. It is classically accepted that STM undergo a consolidation process to form LTM, but the molecular determinants involved are not well understood. Among the molecular components relevant for memory formation, we focused our attention on the protein kinase C (PKC) family of enzymes since they control key aspects of the synaptic plasticity and memory. Within the different PKC isoforms, PKC-gamma has been specifically associated with learning and memory since mice lacking this isoform (PKC-gamma KO mice) showed mild cognitive impairment and deficits in hippocampal synaptic plasticity. We now reveal that PKC-gamma KO mice present a severe impairment in hippocampal-dependent STM using different memory tests including the novel object-recognition and novel place-recognition, context fear conditioning and trace fear conditioning. In contrast, no differences between genotypes were observed in an amygdala-dependent test, the delay fear conditioning. Strikingly, all LTM tasks that could be assessed 24 h after acquisition were not perturbed in the KO mice. The analysis of c-Fos expression in several brain areas after trace fear conditioning acquisition showed a blunted response in the dentate gyrus of PKC-gamma KO mice compared with WT mice, but such differences between genotypes were absent when the amygdala or the prefrontal cortex were examined. In the hippocampus, PKC-gamma was found to translocate to the membrane after auditory trace, but not after delay fear conditioning. Together, these results indicate that PKC-gamma dysfunction affects specifically hippocampal-dependent STM performance and disclose PKC-gamma as a molecular player differentially involved in STM and LTM processes., This work was supported by the Ministerio de Economía, Innovación y Competitividad (MINECO) [#BFU2015-68568-P to A.O., #SAF2017-84060-R to R.M.]; the Instituto de Salud Carlos III [#RD16/0017/0020 to R.M.]; the Ministerio de Ciencia, Innovación y Universidades [# RTI2018-099282-B-I00 (AEI/FEDER/UE) to A.O.]; the Generalitat de Catalunya [2017SGR-669 to R.M.]; the ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M.; Grant “Unidad de Excelencia María de Maeztu,” funded by the MINECO [#MDM-2014-0370]; PLAN E (Plan Español para el Estímulo de la Economía y el Empleo). FEDER funding is also acknowledged.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cell-type- and region-specific modulation of cocaine seeking by micro-RNA-1 in striatal projection neurons

  • Forget, Benoit
  • Martín García, Elena, 1975-
  • Godino, Arthur
  • Domingo Rodriguez, Laura, 1992-
  • Kappes, Vincent
  • Poirier, Pierre
  • Andrianarivelo, Andry
  • Senabre, Eric
  • Allichon, Marie-Charlotte
  • Marias, Mélanie
  • Vanhoutte, Peter
  • Girault, Jean-Antoine
  • Maldonado, Rafael, 1961-
  • Caboche, Jocelyne
The persistent and experience-dependent nature of drug addiction may result in part from epigenetic alterations, including non-coding micro-RNAs (miRNAs), which are both critical for neuronal function and modulated by cocaine in the striatum. Two major striatal cell populations, the striato-nigral and striato-pallidal projection neurons, express, respectively, the D1 (D1-SPNs) and D2 (D2-SPNs) dopamine receptor, and display distinct but complementary functions in drug-evoked responses. However, a cell-type-specific role for miRNAs action has yet to be clarified. Here, we evaluated the expression of a subset of miRNAs proposed to modulate cocaine effects in the nucleus accumbens (NAc) and dorsal striatum (DS) upon sustained cocaine exposure in mice and showed that these selected miRNAs were preferentially upregulated in the NAc. We focused on miR-1 considering the important role of some of its predicted mRNA targets, Fosb and Npas4, in the effects of cocaine. We validated these targets in vitro and in vivo. We explored the potential of miR-1 to regulate cocaine-induced behavior by overexpressing it in specific striatal cell populations. In DS D1-SPNs miR-1 overexpression downregulated Fosb and Npas4 and reduced cocaine-induced CPP reinstatement, but increased cue-induced cocaine seeking. In DS D2-SPNs miR-1 overexpression reduced the motivation to self-administer cocaine. Our results indicate a role of miR1 and its target genes, Fosb and Npas4, in these behaviors and highlight a precise cell-type- and region-specific modulatory role of miR-1, illustrating the importance of cell-specific investigations., This work was supported by Fondation pour la Recherche Médicale (DEQ20150734352 to JC), Centre National pour la Recherche Scientifique (CNRS, B.F., A.G., V.K., P.P., P.V., J.C.), Institut National pour la Santé et la Recherche Médicale (INSERM; B.F., A.G., V.K., P.P., P.V., J.-A.G., J.C.), Sorbonne Université, Faculté des Sciences et Ingénierie (B.F., A.G., V.K., P.P., P.V., J.-A.G., J.C.) Labex Biopsy Investissements d’Avenir, ANR-11-IDEX-0004-02 (B.F., A.G., V.K., P.P., P.V., J.-A.G., J.C.), the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE; E.M.-G., L.D.-R., R.M.), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023; E.M.-G., L.D.-R., R.M.), the Generalitat de Catalunya, AGAUR (#2017-SGR-669; E.M.-G., L.D.-R., R.M.), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) to E.M.-G. Fondation pour la Recherche Médicale (FRM#DPA20140629798) and ANR (ANR-16-CE16-0018) to J.A.G.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

  • Navarro-Romero, Alba
  • Vázquez-Oliver, Anna
  • Gomis González, Maria, 1988-
  • Garzón-Montesinos, Carlos
  • Falcón-Moya, Rafael
  • Pastor, Antonio
  • Martín García, Elena, 1975-
  • Pizarro Lozano, Mª Nieves
  • Busquets Garcia, Arnau, 1985-
  • Revest, Jean-Michel
  • Piazza, Pier Vincenzo
  • Bosch, Fatima
  • Dierssen, Mara
  • Torre Fornell, Rafael de la
  • Rodríguez-Moreno, Antonio
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
Intellectual disability is the most limiting hallmark of Down syndrome, for which there is no gold-standard clinical treatment yet. The endocannabinoid system is a widespread neuromodulatory system involved in multiple functions including learning and memory processes. Alterations of this system contribute to the pathogenesis of several neurological and neurodevelopmental disorders. However, the involvement of the endocannabinoid system in the pathogenesis of Down syndrome has not been explored before. We used the best-characterized preclinical model of Down syndrome, the segmentally trisomic Ts65Dn model. In male Ts65Dn mice, cannabinoid type-1 receptor (CB1R) expression was enhanced and its function increased in hippocampal excitatory terminals. Knockdown of CB1R in the hippocampus of male Ts65Dn mice restored hippocampal-dependent memory. Concomitant with this result, pharmacological inhibition of CB1R restored memory deficits, hippocampal synaptic plasticity and adult neurogenesis in the subgranular zone of the dentate gyrus. Notably, the blockade of CB1R also normalized hippocampal-dependent memory in female Ts65Dn mice. To further investigate the mechanisms involved, we used a second transgenic mouse model overexpressing a single gene candidate for Down syndrome cognitive phenotypes, the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A). CB1R pharmacological blockade similarly improved cognitive performance, synaptic plasticity and neurogenesis in transgenic male Dyrk1A mice. Our results identify CB1R as a novel druggable target potentially relevant for the improvement of cognitive deficits associated with Down syndrome., A.N.-R. is the recipient of a predoctoral fellowship (Ministerio de Educación y Cultura, Spain). A.V.-O. is the recipient of a predoctoral fellowship from Jérôme Lejeune Foundation, France (Spanish Delegation). M.G.-G. was partially supported by FRAXA Research Foundation, United States. A.B-G. was the recipient of a predoctoral fellowship (Ministerio de Educación y Cultura). This study was supported by Jérôme Lejeune Foundation (French Delegation) to A.O.; Instituto de Salud Carlos III, Spain (#RD16/0017/0020) to R.M.; Ministerio de Economía, Innovación y Competitividad (MINECO), Spain (#BFU2015-68568-P to A.O., #SAF2014-59648-P and #SAF2017- 84060-R to R.M.; SAF2016-79956-R to M.D.); Catalan Foundation ‘La Marató de TV3’, Spain (#2016/20-30) to E.M.-G.; Junta de Andalucía, Spain (CVI-7290 to A.R.-M.); Generalitat de Catalunya, Spain (2014SGR-1547 and 2017SGR-669 to R.M.; 2014SGR-1125 to M.D.) and ICREA (Institució Catalana de Recerca i Estudis Avançats, Spain) Academia to A.O. and R.M. Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO (#MDM-2014-0370); PLAN E, Spain (Plan Español para el Estímulo de la Economía y el Empleo); FEDER, European Commission funding is also acknowledged
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Grande, María T.
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Nicotine withdrawal is associated with cognitive deficits including attention, working memory, and episodic memory impairments. These cognitive deficits are a hallmark of nicotine abstinence which could be targeted in order to prevent smoking relapse. The underlying mechanisms, however, are poorly understood. In this study, memory impairment was observed in mice 4 days after the precipitation of nicotine withdrawal by the nicotinic antagonist mecamylamine. The presence of cognitive deficits correlated with microglial activation in the hippocampus and the prefrontal cortex. Moreover, an increased expression of neuroinflammatory markers including IL1β, TNFα and IFNγ was found in both memory-related brain regions. Notably, flow cytometric analysis also revealed an enhancement of TNFα and IFNγ plasmatic levels at the same time point during nicotine withdrawal. Impaired neurogenesis, as shown by reduction in the expression of the endogenous cell proliferation marker Ki67 and the early neuron marker doublecortin, was also associated with nicotine abstinence. Treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of IL1β and IFNγ in the hippocampus and the prefrontal cortex, respectively, and normalized Ki67 levels. The nonsteroidal anti-inflammatory drug indomethacin also prevented cognitive deficits and microglial reactivity during withdrawal. These data underline the usefulness of anti-inflammatory agents to improve cognitive performance during early nicotine abstinence., This work was supported by “Plan Nacional sobre Drogas”(#2014I019) and “Ministerio de Economía y Competitividad” MINECO/FEDER, UE (SAF2017-85299-R) to FB, the “Generalitat deCatalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM. Rocio Saraviais a recipient of a predoctoral fellowship from the “Instituto de Salud Carlos III”
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Vulnerability to addiction

  • Maldonado, Rafael, 1961-
  • Calvé Pérez, Pablo, 1993-
  • García Blanco, Alejandra
  • Domingo Rodriguez, Laura, 1992-
  • Senabre, Eric
  • Martín García, Elena, 1975-
Addiction is a chronic brain disease that has dramatic health and socioeconomic consequences worldwide. Multiple approaches have been used for decades to clarify the neurobiological basis of this disease and to identify novel potential treatments. This review summarizes the main brain networks involved in the vulnerability to addiction and specific innovative technological approaches to investigate these neural circuits. First, the evolution of the definition of addiction across the Diagnostic and Statistical Manual of Mental Disorders (DSM) is revised. We next discuss several innovative experimental techniques that, combined with behavioral approaches, have allowed recent critical advances in understanding the neural circuits involved in addiction, including DREADDs, calcium imaging, and electrophysiology. All these techniques have been used to investigate specific neural circuits involved in vulnerability to addiction and have been extremely useful to clarify the neurobiological basis of each specific component of the addictive process. These novel tools targeting specific brain regions are of great interest to further understand the different aspects of this complex disease. This article is part of the special issue on 'Vulnerabilities to Substance Abuse.'., This work was supported by the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017-SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan NAcional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) and Plan NAcional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2019I006) to E.M-G. Figures are created with BioRender.com.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Influence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain

  • Martínez-Navarro, Miriam
  • Lara Mayorga, Itzel Montserrat, 1982-
  • Negrete Buela, Roger
  • Bilecki, Wiktor
  • Wawrzczak-Bargiela, Agnieszka
  • Gonçalves, Leonor
  • Dickenson, Anthony Henry
  • Przewlocki, Ryszard
  • Baños i Díez, Josep Eladi
  • Maldonado, Rafael, 1961-
Neuropathic pain is a complex disorder associated with emotional and cognitive deficits that may impair nociceptive manifestations. There is high inter-individual variability in the manifestations of human neuropathic pain, which largely depends on personality traits. We aim to identify the influence of different behavioral traits in the interindividual vulnerability to neuropathic pain manifestations using behavioral, electrophysiological and genetic approaches. We first selected mice with extreme social and emotional traits and look for correlation with the spontaneous neuronal activity in the central amygdala. Neuropathic pain was induced to these mice to evaluate the influence of behavioral traits on nociceptive manifestations and gene expression profiles in the amygdala. Our results show an association of the spontaneous central amygdala neuronal activity with the sociability behavior. We demonstrate that low sociable, high anxious and low depressive phenotypes develop enhanced nociceptive hypersensitivity after nerve injury. However, greater emotional alterations and cognitive impairment are observed in high sociable, anxious-like and depressive-like mice, indicating that nociceptive, emotional and cognitive manifestations of neuropathic pain do not correlate with each other. Gene analyses identify high Pdyn and Il6 levels in the amygdala as indicative of enhanced nociceptive hypersensitivity and reveal an association between high Gadd45 expression and attenuated emotional and cognitive manifestations of neuropathic pain., This work was supported by the European Commission, FP7 (#HEALTH-F2-2013- 602891), the Spanish Ministerio de Economía y Competitividad MINECO (#SAF2014-59648-P and #SAF2017-84060-R), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023) and the Generalitat de Catalunya, AGAUR (#2014-SGR-1547) and Polish Ministry of Science and Education (#3070/7.PR/2014/2). M.M.N. and R.N. are recipients of a predoctoral fellowship from the Spanish Ministerio de Educación, Cultura y Deporte (MECD). I.M.L.M. is recipient of a predoctoral fellowship from the Mexican Consejo Nacional de Ciencia y Tecnología (CONACyT). FEDER partial funding is also acknowledged. W.B. and A.B. are recipients of Polish Ministry of Science and Education and European Commission grants
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Luque-Córdoba, Diego
  • Priego-Capote, Feliciano
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Burokas, Aurelijus, 1982-
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Background: Gonadal steroid hormones have been suggested as the underlying mechanism responsible for the sexual dimorphism observed in metabolic diseases. Animal studies have also evidenced a causal role of the gut microbiome and metabolic health. However, the role of sexual dimorphism in the gut microbiota and the potential role of the microbiome in influencing sex steroid hormones and shaping sexually dimorphic susceptibility to disease have been largely overlooked. Although there is some evidence of sex-specific differences in the gut microbiota diversity, composition, and functionality, the results are inconsistent. Importantly, most of these studies have not taken into account the gonadal steroid status. Therefore, we investigated the gut microbiome composition and functionality in relation to sex, menopausal status, and circulating sex steroids. Results: No significant differences were found in alpha diversity indices among pre- and post-menopausal women and men, but beta diversity differed among groups. The gut microbiota from post-menopausal women was more similar to men than to pre-menopausal women. Metagenome functional analyses revealed no significant differences between post-menopausal women and men. Gonadal steroids were specifically associated with these differences. Hence, the gut microbiota of pre-menopausal women was more enriched in genes from the steroid biosynthesis and degradation pathways, with the former having the strongest fold change among all associated pathways. Microbial steroid pathways also had significant associations with the plasma levels of testosterone and progesterone. In addition, a specific microbiome signature was able to predict the circulating testosterone levels at baseline and after 1-year follow-up. In addition, this microbiome signature could be transmitted from humans to antibiotic-induced microbiome-depleted male mice, being able to predict donor's testosterone levels 4 weeks later, implying that the microbiota profile of the recipient mouse was influenced by the donor's gender. Finally, obesity eliminated most of the differences observed among non-obese pre-menopausal women, post-menopausal women, and men in the gut microbiota composition (Bray-Curtis and weighted unifrac beta diversity), functionality, and the gonadal steroid status. Conclusions: The present findings evidence clear differences in the gut microbial composition and functionality between men and women, which is eliminated by both menopausal and obesity status. We also reveal a tight link between the gut microbiota composition and the circulating levels of gonadal steroids, particularly testosterone. Video Abstract., This work was partially supported by research grants FIS (PI15/01934) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and AEI-SAF2017-84060-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain, and also by European Commission (FP7, NeuroPain #2013-602891; #H2020-SC1-2019-2-RTD-848099 (PAINFACT)), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Fondo Europeo de Desarrollo Regional (FEDER) through the Programa Interreg V-A España-Francia-Andorra (POCTEFA 2014-2020), and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). María Arnoriaga Rodríguez is funded by a predoctoral Río Hortega contract (CM19/00190, co-funded by European Social Fund “Investing in your future”) from the Instituto de Salud Carlos III, Spain. Jordi Mayneris-Perxachs is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Delta9-tetrahydrocannabinol modulates the proteasome system in the brain

  • Salgado Mendialdúa, Victòria
  • Aguirre Plans, Joaquim, 1993-
  • Guney, Emre
  • Reig-Viader, Rita
  • Maldonado, Rafael, 1961-
  • Bayés, Angels
  • Oliva Miguel, Baldomero
  • Ozaita Mintegui, Andrés, 1969-
Cannabis is the most consumed illicit drug worldwide. Its principal psychoactive component, Δ9-tetrahydrocannabinol (THC), affects multiple brain functions, including cognitive performance, by modulating cannabinoid type-1 (CB1) receptors. These receptors are strongly enriched in presynaptic terminals, where they modulate neurotransmitter release. We analyzed, through a proteomic screening of hippocampal synaptosomal fractions, those proteins and pathways modulated 3 h after a single administration of an amnesic dose of THC (10 mg/kg, i.p.). Using an isobaric labeling approach, we identified 2040 proteins, 1911 of them previously reported in synaptic proteomes, confirming the synaptic content enrichment of the samples. Initial analysis revealed a significant alteration of 122 proteins, where 42 increased and 80 decreased their expression. Gene set enrichment analysis indicated an over-representation of mitochondrial associated functions and cellular metabolic processes. A second analysis focusing on extreme changes revealed 28 proteins with altered expression after THC treatment, 15 of them up-regulated and 13 down-regulated. Using a network topology-based scoring algorithm we identified those proteins in the mouse proteome with the greatest association to the 28 modulated proteins. This analysis pinpointed a significant alteration of the proteasome function, since top scoring proteins were related to the proteasome system (PS), a protein complex involved in ATP-dependent protein degradation. In this regard, we observed that THC decreases 20S proteasome chymotrypsin-like protease activity in the hippocampus. Our data describe for the first time the modulation of the PS in the hippocampus following THC administration under amnesic conditions that may contribute to an aberrant plasticity at synapses., This study was supported by Grants from the Ministerio de Economía, Innovación y Competitividad (MINECO) (#BFU2015-68568-P (MINECO/FEDER, UE) to A.O., #BFU2015-69717-P (MINECO/FEDER, UE) to RRV and AB, #RYC-2011-08391 to AB, #SAF2017-90664-REDT to RRV and AB, #SAF2014-59648-P and #SAF2017-84060-R to R.M.; a grant from the Instituto de Salud Carlos III (#RD16/0017/0020) to R.M.; Generalitat de Catalunya (2017SGR-669 to R.M. and 2017SGR1776 to RRV and AB) and ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M. Mass spectrometric analyses were performed at the CRG/UPF Proteomics Unit which is part of the of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF. Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO (#MDM-2014-0370); PLAN E (Plan Español para el Estímulo de la Economía y el Empleo); FEDER funding is also acknowledged
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior

  • Navandar, Mohit
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Lutz, Beat
  • Gerber, Susanne
  • Ruiz de Azua, Iñigo
Addiction is a chronic relapsing brain disease characterized by compulsive reward-seeking despite harmful consequences. The mechanisms underlying addiction are orchestrated by transcriptional reprogramming in the reward system of vulnerable subjects. This study aims at revealing gene expression alterations across different types of addiction. We analyzed publicly available transcriptome datasets of the prefrontal cortex (PFC) from a palatable food and a cocaine addiction study. We found 56 common genes upregulated in the PFC of addicted mice in these two studies, whereas most of the differentially expressed genes were exclusively linked to either palatable food or cocaine addiction. Gene ontology analysis of shared genes revealed that these genes contribute to learning and memory, dopaminergic synaptic transmission, and histone phosphorylation. Network analysis of shared genes revealed a protein-protein interaction node among the G protein-coupled receptors (Drd2, Drd1, Adora2a, Gpr6, Gpr88) and downstream targets of the cAMP signaling pathway (Ppp1rb1, Rgs9, Pde10a) as a core network in addiction. Upon extending the analysis to a cell-type specific level, some of these common molecular players were selectively expressed in excitatory neurons, oligodendrocytes, and endothelial cells. Overall, computational analysis of publicly available whole transcriptome datasets provides new insights into the molecular basis of addiction-like behaviors in PFC., We thank the financial support of the Spanish “Ministerio de Ciencia, Innovación y Universidades” (#AEI-SAF2017-84060-R FEDER), the “Instituto de Salud Carlos III” (#RD16/0017/0020), the “Plan Nacional Sobre Drogas” of the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad” (#RD16/0017/0020 & #PNSD-2017I068) and the AGAUR of the “Generalitat de Catalunya” (#2017-SGR-669 and #ICREA-Acadèmia 2015) to R.M. and Fundació La Marató-TV3 (#2016/20-30) and Plan Nacional Sobre Drogas (#PNSD-2019I006) to E.M.G.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model

  • Vázquez-Oliver, Anna
  • Brambilla Pisoni, Cecilia, 1993-
  • Domingo-Gainza, Mikel
  • Maldonado, Rafael, 1961-
  • Ivorra Cano, Antoni, 1974-
  • Ozaita Mintegui, Andrés, 1969-
Background: Vagus nerve stimulation (VNS) using non-invasive approaches have attracted great attention due to their anti-epileptic, anti-depressive and pro-cognitive effects. It has been proposed that auricular transcutaneous VNS (atVNS) could benefit intellectual disability disorders, but preclinical data supporting this idea is limited. Objective: To develop an atVNS device for mice and to test its efficacy on memory performance in naïve mice and in a mouse model for intellectual disability. Methods: Naïve outbreed CD-1 mice and a model for fragile X syndrome, the Fmr1 knockout (Fmr1KO), were used to assess the effect of atVNS in the novel object-recognition memory performance. Results: We found that atVNS significantly improves memory persistence in naïve mice. Notably, atVNS was efficacious in normalizing the object-recognition memory deficit in the Fmr1KO model. Conclusion: Our data show that atVNS improves memory persistence in naïve mice and in a model of intellectual disability and support further studies taking advantage of preclinical mouse models of cognitive disorders., This work was supported by a Predoctoral fellowship from Jerome Lejeune Foundation (Spanish division) (A.V.-O.) and from “la Caixa” Foundation (ID 100010434), LCF/BQ/IN18/11660012 and European Union’s Horizon 2020 research and innovation programme under the Marie Slodowska-Curie grant agreement No. 713673 (C.B.-P.). Ministerio de Economía, Innovación y Competitividad (MINECO) [#RTI2018-099282-B-I00 to A.O., #SAF2017-84060-R to R.M.]; the Instituto de Salud Carlos III [#RD16/0017/0020 to R.M.]; the Generalitat de Catalunya [2017SGR-669 to R.M.]; the ICREA (Institució Catalana de Recerca i Estudis Avançats) Acadèmia to A.O., A.I. and R.M.; Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO [#MDM-2014-0370]; PLAN E (Plan Español para el Estímulo de la Economía y el Empleo). FEDER (Fondo Europeo de Desarrollo Regional) funding is also acknowledged
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Why mu-opioid agonists have less analgesic efficacy in neuropathic pain?

  • Martínez-Navarro, Miriam
  • Maldonado, Rafael, 1961-
  • Baños i Díez, Josep Eladi
Injury to peripheral nerves often leads to abnormal pain states (hyperalgesia, allodynia and spontaneous pain), which can remain long after the injury heals. Although opioid agonists remain the gold standard for the treatment of moderate to severe pain, they show reduced efficacy against neuropathic pain. In addition to analgesia, opioid use is also associated with hyperalgesia and analgesia tolerance, whose underlying mechanisms share some commonalities with nerve injury-induced hypersensitivity. Here, we reviewed up-to-day research exploring the contribution of mu-opioid receptor (MOR) on the pathophysiology of neuropathic pain and on analgesic opioid actions under these conditions. We focused on the specific contributions of MOR populations at peripheral, spinal and supraspinal level. Moreover, evidences of neuroplastic changes that may underlie the low efficacy of MOR agonists under neuropathic pain conditions are reviewed and discussed. Sensitization processes leading to pain hypersensitivity, molecular changes in signalling pathways triggered by MOR and glial activation are some of these mechanisms elicited by both nerve injury and opioid exposure. Nerve injury-induced pain hypersensitivity might be masking the initial analgesic effects of opioid agonists, and alternatively, sustained opioid treatment to individuals already suffering from neuropathic pain could aggravate their pathophysiological state. Finally, some combined therapies that can increase opioid analgesic effectiveness in neuropathic pain treatment are highlighted. SIGNIFICANCE: This review provides evidence of the low benefit of opioid monotherapy in neuropathic pain and analyses the reasons of this reduced effectiveness. Opioid agonists along with drugs targeted to block the sensitization processes induced by MOR stimulation might result in a better management of neuropathic pain., We acknowledge the financial support of the European Commission FP7. Grant Number: #HEALTH‐F2‐2013‐602891; Spanish Ministry of Science, Innovation and Universities. Grant Number: #SAF2017‐84060‐R‐AEI/FEDER‐UE; Instituto de Salud Carlos III. Grant Number: RETICS/RTA #RD16/0017; Catalan Government AGAUR. Grant Numbers: #ICREA Acadèmia‐2015, #2017‐SGR‐669; Spanish MECD
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Protective role of neuronal and lymphoid cannabinoid CB 2 receptors in neuropathic pain

  • Cabañero Ferri, David
  • Ramírez-López, Angela
  • Drews, Eva
  • Schmöle, Anne
  • Otte, David M.
  • Wawrzczak-Bargiela, Agnieszka
  • Huerga Encabo, Hector, 1989-
  • Kummer, Sami, 1985-
  • Ferrer-Montiel, Antonio
  • Przewlocki, Ryszard
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
Cannabinoid CB2 receptor (CB2) agonists are potential analgesics void of psychotropic effects. Peripheral immune cells, neurons and glia express CB2; however, the involvement of CB2 from these cells in neuropathic pain remains unresolved. We explored spontaneous neuropathic pain through on-demand self-administration of the selective CB2 agonist JWH133 in wild-type and knockout mice lacking CB2 in neurons, monocytes or constitutively. Operant self-administration reflected drug-taking to alleviate spontaneous pain, nociceptive and affective manifestations. While constitutive deletion of CB2 disrupted JWH133-taking behavior, this behavior was not modified in monocyte-specific CB2 knockouts and was increased in mice defective in neuronal CB2 knockouts suggestive of increased spontaneous pain. Interestingly, CB2-positive lymphocytes infiltrated the injured nerve and possible CB2transfer from immune cells to neurons was found. Lymphocyte CB2depletion also exacerbated JWH133 self-administration and inhibited antinociception. This work identifies a simultaneous activity of neuronal and lymphoid CB2that protects against spontaneous and evoked neuropathic pain., This paper was supported by the following grants: European Commission NeuroPain, FP7-602891-2 to Rafael Maldonado. Instituto de Salud Carlos III RTA, RD16/0017/0020/FEDER to Rafael Maldonado. Ministerio de Ciencia, Innovación y Universidades SAF2017-84060-R FEDER to Rafael Maldonado. Generalitat de Catalunya SGR2017-669, ICREA Academia Award 2015 to Rafael Maldonado. Generalitat de Catalunya 2018 FI_B 00207 to Angela Ramírez-López. Polish Ministry of Science and Education 3070/7.PR/2014/2 to Ryszard Przewlocki. Spanish Ministry of Science, Innovation and Universities 2018-097189-B-C21 to Antonio Ferrer-Montiel. Universidad Miguel Hernandez UMH-PAR2019 to Antonio Ferrer-Montiel.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Role of the endocannabinoid system in drug addiction

  • Manzanares, Jorge
  • Cabañero Ferri, David
  • Puente, Nagore
  • García-Gutiérrez, María S.
  • Grandes, Pedro
  • Maldonado, Rafael, 1961-
Drug addiction is a chronic relapsing disorder that produces a dramaticglobal health burden worldwide. Not effective treatment of drug addiction is currently available probably due to the difficulties to find an appropriate target to manage this complex disease raising the needs for further identification of novel therapeutic approaches. The endocannabinoid system has been found to play a crucial role in the neurobiological substrate underlying drug addiction. Endocannabinoids and cannabinoid receptors are widely expressed in the main areas of the mesocorticolimbic system that participate in the initiation and maintenance of drug consumption and in the development of compulsion and loss of behavioral control occurring during drug addiction. The identification of the important role played by CB1 cannabinoid receptors in drug addiction encouraged the possible used of an early commercialized CB1 receptor antagonist for treating drug addiction. However, the incidence of serious psychiatric adverse events leaded to the sudden withdrawal from the market of this CB1 antagonist and all the research programs developed by pharmaceutical companies to obtain new CB1 antagonists were stopped. Currently, new research strategies are under development to target the endocannabinoid system for drug addiction avoiding these side effects, which include allosteric negative modulators of CB1 receptors and compounds targeting CB2 receptors. Recent studies showing the potential role of CB2 receptors in the addictive properties of different drugs of abuse have open a promising research opportunity to develop novel possible therapeutic approaches., We acknowledge the financial support of the Spanish MINECO (#SAF2017-84060-R-AEI/FEDER-UE), Instituto de Salud Carlos III-RETICS(##RD16/0017/0020), Ministerio de Sanidad, Servicios Sociales e Igualdad-Plan Nacional Sobre Drogas (#PNSD-2017I068), and the Generalitat de Catalunya-AGAUR ((#2017-SGR-669 and #ICREA Acadèmia2015) and the European Commission-DG RTD (#FP7-HEALTH-F2-2013-602891-NeuroPain) to RM. FEDER funding support is also acknowledged. This work was supported by Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU) (RD16/0017/0012), The Basque Government (BCG IT764-13) and MINECO/FEDER, UE(SAF2015-65034-R) to PG. This research was supported by Instituto de Salud Carlos III (RETICS, RD12/0028/0019, RD16/0017/0014 and RD06/0001/1004), Plan Nacional Sobre Drogas (PNSD 2016/016 and 2007/061), Ministerio de Economía y Competitividad (FIS, PI14/00438) and Ministerio de Ciencia e Innovación (SAF2008-01106) to JM
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Surgical induction of endometriosis in female mice

  • Escudero Lara, Alejandra, 1992-
  • Cabañero Ferri, David
  • Maldonado, Rafael, 1961-
Endometriosis is a common gynecological disease characterized by the presence of endometrial tissue outside the uterine cavity. It is frequently associated with pain, infertility and a reduced quality of life, and it lacks adequate treatment. Several rodent models of endometriosis have been developed through heterologous and homologous transplantation of endometrial tissue into the abdominal compartment. Here we describe a surgical procedure to generate a syngeneic model of endometriosis in immunocompetent mice with intact uterine and ovarian tissues. In this model, four uterine fragments from a donor mouse at diestrus are sutured to the abdominal wall of a recipient mouse. One month after surgeries, endometrial implants develop into cysts with glandular epithelium and stroma, mimicking the endometriotic lesions observed in women with endometriosis. Therefore, this mouse model provides a valuable tool to study the pathophysiology of endometriosis and the efficacy of potential treatments., “Instituto de Salud Carlos III”, “Redes temáticas de investigación cooperativa en salud–Red de trastornos adictivos” (#RD16/0017/0020), “Ministerio de Ciencia, Innovación y Universidades”, MCIU (#SAF2017-84060-R-AEI/FEDER-UE), “Generalitat de Catalunya- Agència de Gestió d'Ajuts Universitaris i de Recerca-AGAUR" (#2017-SGR-669 and #ICREA Acadèmia2015) to R.M. are acknowledged.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Operant self-medication for assessment of spontaneous pain relief and drug abuse liability in mouse models of chronic pain

  • Cabañero Ferri, David
  • Álvarez-Pérez, Beltrán
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The search for safe and efficient chronic pain treatments is dampened by the lack of reliable models that faithfully reproduce current pharmacological treatments for chronic spontaneous pain in humans. Preclinical models often assess the antinociceptive efficacy of non-contingent pharmacological treatments evaluated in the short-term. Here, we provide a protocol of contingent operant self-medication in mice, which allows the estimation of spontaneous pain relief and drug abuse liability in models of persistent pain. This paradigm requires preliminary habituation and animal handling, followed by training of mice in operant conditioning boxes, to allow subsequent analgesic drug self-administration. After the initial acquisition of food-maintained operant behavior, a chronic pain sensitization is induced. Posterior intravenous jugular catheterization and coupling of operant conditioning boxes to perfusion pumps allow quantification of operant responding for intravenous drug self-administration. All mice show an initial operant drug self-administration behavior associated with the previous food-maintained operant training. This initial operant responding is extinguished after administration of ineffective treatments, but continues when the compounds have analgesic efficacy or intrinsic reinforcing properties. The identification of a significant drug self-administration selectively expressed in mice exposed to the chronic pain condition is indicative of analgesic drug effects, whereas persistent self-administration in control mice is indicative of abuse liability. The present protocol provides the behavioral and surgical procedures needed to assess spontaneous pain relief and potential for abuse of pharmacological treatments, through contingent analgesic self-medication in mice., This work was supported by the European Comission [NeuroPain, FP7-602891-2], the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848068 [QSPainRelief, H2020-SC1-2019-2-RTD-848068], the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R- AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD- 2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) and Plan Nacional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2019I006) to E.M-G. The methodology described was previously used in Bura et al. (2013, 2018) and Cabañero et al. (2020, doi: 10.7554/eLife.55582). Authors also want to thank E. Senabre and R. Martín for their critics and technical support.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

  • Domingo Rodriguez, Laura, 1992-
  • Ruiz de Azua, Iñigo
  • Domínguez, Eduardo
  • Senabre, Eric
  • Serra, Irene
  • Kummer, Sami, 1985-
  • Navandar, Mohit
  • Baddenhausen, Sarah
  • Hofmann, Clementine
  • Andero, Raül
  • Gerber, Susanne
  • Navarrete, Marta
  • Dierssen, Mara
  • Lutz, Beat
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Food addiction is linked to obesity and eating disorders and is characterized by a loss of behavioral control and compulsive food intake. Here, using a food addiction mouse model, we report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic neurons prevents the development of food addiction-like behavior, which is associated with enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological mechanism underlying resilience and vulnerability to the development of food addiction, which could pave the way towards novel and efficient interventions for this disorder., This work was supported by the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) to E.M-G., the German Research Foundation (#CRC1193 “Neurobiology of Resilience”, TP A05 and B04) to B.L. and S.G., and the Boehringer Ingelheim Foundation to B.L., S.G. and I.R.A. The work of M.N.A was supported by the Emergent AI Center funded by the Carl-Zeiss-Stiftung. NARSAD Young Investigator Award (#22434), MINECO Ramón y Cajal (#RYC- 2014-15784) and (#SAF2016-76565-R) and Fondo Europeo de Desarrollo Regional (FEDER) to R.A. DIUE Generalitat de Catalunya (#2017 SGR 595), MINECO (#SAF2016-79956-R), EU (#Era Net Neuron PCIN-2013-060), Fundació La Marató-TV3 (#2016/20-31), CRG acknowledges support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Center of Excellence Severo Ochoa (#SEV-2012-0208), the CERCA Programme/Generalitat de Catalunya, the CIBER of Rare Diseases of the ISCIII to M.D. MINECO Ramón y Cajal (#RYC-2016-20414), AGAUR (#2017 SGR 926), (#RTI2018-094887-B-I00) and Fondo Europeo de Desarrollo Regional (FEDER) to M.N.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Rationale: Cannabis use is typically initiated during adolescence, and different studies suggest that adolescent cannabinoid exposure may increase the risk for drug addiction in adulthood. Objectives: This study investigated the effects of adolescent exposure to the main psychoactive component of cannabis, ∆9-tetrahydrocannabinol (THC), in the reinforcing properties of nicotine in adult male mice. Possible alterations in relapse to nicotine-seeking behaviour in adult animals due to THC adolescent exposure were also evaluated. Methods: Adolescent mice were exposed to escalating doses of THC from PND35 to PND49. When mice reached adulthood (PND70), surgical procedures were applied for further behavioural evaluation. Nicotine self-administration sessions were conducted consecutively for 10 days. Following extinction, mice were tested for cue- and stress-induced reinstatement of nicotine-seeking behaviour. Results: Adolescent THC treatment did not modify acquisition and extinction of nicotine self-administration in adulthood. Moreover, THC exposure did not alter relapse to nicotine seeking induced by stress or nicotine-associated cues. Conclusions: These results suggest that a history of exposure to THC during adolescence under these particular conditions does not modify the reinforcing effects and seeking behaviour of nicotine in the adult period., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the “Generalitat de Catalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain

  • Escudero-Lara, Alejandra
  • Argerich, Josep
  • Cabañero Ferri, David
  • Maldonado, Rafael, 1961-
Endometriosis is a chronic painful disease highly prevalent in women that is defined by growth of endometrial tissue outside the uterine cavity and lacks adequate treatment. Medical use of cannabis derivatives is a current hot topic and it is unknown whether phytocannabinoids may modify endometriosis symptoms and development. Here we evaluate the effects of repeated exposure to Δ9-tetrahydrocannabinol (THC) in a mouse model of surgically-induced endometriosis. In this model, female mice develop mechanical hypersensitivity in the caudal abdomen, mild anxiety-like behavior and substantial memory deficits associated with the presence of extrauterine endometrial cysts. Interestingly, daily treatments with THC (2 mg/kg) alleviate mechanical hypersensitivity and pain unpleasantness, modify uterine innervation and restore cognitive function without altering the anxiogenic phenotype. Strikingly, THC also inhibits the development of endometrial cysts. These data highlight the interest of scheduled clinical trials designed to investigate possible benefits of THC for women with endometriosis., Funding: “Instituto de Salud Carlos III”, “Redes temáticas de investigación cooperativa en salud – Red de trastornos adictivos” (#RD16/0017/0020), “Ministerio de Ciencia, Innovación y Universidades”, MCIU (#SAF2017-84060-R-AEI/FEDER-UE), “Generalitat de Catalunya - Agència de Gestió d'Ajuts Universitaris i de Recerca-AGAUR" (#2017-SGR422 669 and #ICREA Acadèmia2015) to R.M. are acknowledged
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

  • Arnoriaga Rodríguez, María
  • Burokas, Aurelijus, 1982-
  • Ortega Sánchez, Juan Antonio
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Background: Inhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits. Methods: We studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics. Results: An interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (thyX,dut, exodeoxyribonuclease V), and the anterior cingulate cortex volume were associated with IC, cross-sectionally and longitudinally. FMT from individuals with obesity led to alterations in mice reversal learning. In an independent FMT experiment, human donor's bacterial functions related to IC deficits were associated with mPFC expression of one-carbon metabolism-related genes of recipient's mice. Conclusion: These results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts., This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and #AEI-SAF2017-84060-R-FEDER from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Catalan Goverment (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [STL002/16/00250]; the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). MA-R is funded by a predoctoral Río Hortega contract from the Instituto de Salud Carlos III (ISCIII, CM19/00190), co-funded by the European Social Fund “Investing in your future”. OC-R is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP20/00165), co-funded by the Europeran Social Fund "Investing in your future". JM-P is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. JS is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. MJ is a professor under the “Serra Hunter” programme (Generalitat de Catalunya).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions

  • Blanch-Rubió, Josep
  • Soldevila-Domenech, Natalia
  • Tío, Laura
  • Llorente Onaindia, Jone
  • Ciria Recasens, Manuel
  • Polino, Luciano
  • Gurt, Alba
  • Torre Fornell, Rafael de la
  • Maldonado, Rafael, 1961-
  • Monfort, Jordi
  • The Covidmar Study Group
Coronavirus disease 19 (COVID-19) is currently a global pandemic that affects patients with other pathologies. Here, we investigated the influence of treatments for osteoporosis and other non-inflammatory rheumatic conditions, such as osteoarthritis and fibromyalgia, on COVID-19 incidence. To this end, we conducted a cross-sectional study of 2,102 patients being treated at the Rheumatology Service of Hospital del Mar (Barcelona, Spain). In our cohort, COVID-19 cumulative incidence from March 1 to May 3, 2020 was compared to population estimates for the same city. We used Poisson regression models to determine the adjusted relative risk ratios for COVID-19 associated with different treatments and comorbidities. Denosumab, zoledronate and calcium were negatively associated with COVID-19 incidence. Some analgesics, particularly pregabalin and most of the studied antidepressants, were positively associated with COVID-19 incidence, whereas duloxetine presented a negative association. Oral bisphosphonates, vitamin D, thiazide diuretics, anti-hypertensive drugs and chronic non-steroidal anti-inflammatory drugs had no effect on COVID-19 incidence in the studied population. Our results provide novel evidence to support the maintenance of the main anti-osteoporosis treatments in COVID-19 patients, which may be of particular relevance to elderly patients affected by the SARS-CoV-2 pandemic., This study was supported by Hospital del Mar. Authors funding includes “Ministerio de Ciencia, Innovación y Universidades” (#AEI-SAF2017-84060-R FEDER to R.M., #DPI2016-80283-C2-2-R), “Ministerio de Sanidad, Servicios Sociales e Igualdad” (#RD16/0017/0020 & #PNSD-2017I068 to R.M., #PI18/00059 to TCS-M) and “Generalitat de Catalunya” (#2017-SGR-669 & #ICREA- Acadèmia 2015 to R.M., #2017-SGR-138 to R.D.L.T.). N.S.D. is recipient of predoctoral fellowship #2019-DI-47 from the DIUE-AGAUR of the “Generalitat de Catalunya”.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2

  • Martínez-Torres, Sara
  • Cutando Ruiz, Laura, 1985-
  • Pastor, Antonio
  • Kato, Ako
  • Sakimura, Kenji
  • Torre Fornell, Rafael de la
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Kano, Masanobu
  • Ozaita Mintegui, Andrés, 1969-
Monoacylglycerol lipase (MAGL) is the main enzyme implicated in the degradation of the most abundant endocannabinoid in the brain, 2-arachidonoylglycerol (2-AG), producing arachidonic acid (AA) and glycerol. MAGL pharmacological inhibition with JZL184 or genetic deletion results in an exacerbated 2-AG signaling and reduced synthesis of prostaglandins (PGs), due to the reduced AA precursor levels. We found that acute JZL184 administration, previously described to exert anti-inflammatory effects, and MAGL knockout (KO) mice display cerebellar, but not hippocampal, microglial reactivity, accompanied with increased expression of the mRNA levels of neuroinflammatory markers, such as cyclooxygenase-2 (COX-2). Notably, this neuroinflammatory phenotype correlated with relevant motor coordination impairment in the beam-walking and the footprint tests. Treatment with the COX-2 inhibitor NS398 during 5 days prevented the deficits in cerebellar function and the cerebellar microglia reactivity in MAGL KO, without affecting hippocampal reactivity. Altogether, this study reveals the brain region-specific response to MAGL inhibition, with an important role of COX-2 in the cerebellar deficits associated, which should be taken into account for the use of MAGL inhibitors as anti-inflammatory drugs., This work was supported by the Ministerio de Economía, Innovación y Competitividad (MINECO) [#BFU2015-68568-P to A.O., #SAF2017-84060-R to R.M.]; the Instituto de Salud Carlos III [#RD16/0017/0020 to R.M.]; the Generalitat de Catalunya [2017SGR-669 to R.M.]; the ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M.; Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO [#MDM-2014-0370]; PLAN E (Plan Español para el Estímulo de la Economía y el Empleo); Fondation pour la Recherche Médicale to E.V and FEDER funding is also acknowledged.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Contreras-Rodríguez, Oren
  • Burokas, Aurelijus
  • Ortega Sánchez, Juan Antonio
  • Blasco Solà, Gerard
  • Coll, Claudia
  • Biarnés, Carles
  • Castells Nobau, Anna
  • Puig, Josep
  • Garre Olmo, Josep
  • Ramos, Rafel
  • Pedraza, Salvador
  • Brugada, Ramon
  • Vilanova, Joan Carles
  • Serena, Joaquín
  • Barretina Ginesta, Jordi
  • Gich Fullà, Jordi
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Fernández Real, Xavier
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Sol, Joaquim
  • Jové Font, Mariona
  • Ricart, Wifredo
  • Portero Otín, Manuel
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Background Inhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits. Methods We studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics. Results An interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (thyX,dut, exodeoxyribonuclease V), and the anterior cingulate cortex volume were associated with IC, cross-sectionally and longitudinally. FMT from individuals with obesity led to alterations in mice reversal learning. In an independent FMT experiment, human donor’s bacterial functions related to IC deficits were associated with mPFC expression of one-carbon metabolism-related genes of recipient’s mice. Conclusion These results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts., This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015- 65878-R and #AEI-SAF2017-84060-R-FEDER from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Catalan Goverment (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [STL002/16/00250]; the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A SpainFrance-Andorra programme (POCTEFA 2014-2020). MA-R is funded by a predoctoral Río Hortega contract from the Instituto de Salud Carlos III (ISCIII, CM19/00190), co-funded by the European Social Fund “Investing in your future”. OC-R is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP20/00165), co-funded by the Europeran Social Fund "Investing in your future". JM-P is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. JS is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. MJ is a professor under the “Serra Hunter” programme (Generalitat de Catalunya).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

  • Domingo-Rodriguez, L.
  • Ruiz de Azua, I.
  • Domínguez, Eduardo
  • Senabre, E.
  • Serra, Irene
  • Kummer, S.
  • Navandar, M.
  • Baddenhausen, S.
  • Hofmann, C.
  • Andero, R
  • Gerber, S.
  • Navarrete, Marta
  • Dierssen, Mara
  • Lutz, Beat
  • Martín-García, Elena
  • Maldonado, Rafael
Food addiction is linked to obesity and eating disorders and is characterized by a loss of behavioral control and compulsive food intake. Here, using a food addiction mouse model, we report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic neurons prevents the development of food addiction-like behavior, which is associated with enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological mechanism underlying resilience and vulnerability to the development of food addiction, which could pave the way towards novel and efficient interventions for this disorder., This work was supported by the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) to E.M-G., the German Research Foundation (#CRC1193 “Neurobiology of Resilience”, TP A05 and B04) to B.L. and S.G., and the Boehringer Ingelheim Foundation to B.L., S.G. and I.R.A. The work of M.N.A was supported by the Emergent AI Center funded by the Carl-Zeiss-Stiftung. NARSAD Young Investigator Award (#22434), MINECO Ramón y Cajal (#RYC- 2014-15784) and (#SAF2016-76565-R) and Fondo Europeo de Desarrollo Regional (FEDER) to R.A. DIUE Generalitat de Catalunya (#2017 SGR 595), MINECO (#SAF2016-79956-R), EU (#Era Net Neuron PCIN-2013-060), Fundació La Marató-TV3 (#2016/20-31), CRG acknowledges support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Center of Excellence Severo Ochoa (#SEV-2012-0208), the CERCA Programme/Generalitat de Catalunya, the CIBER of Rare Diseases of the ISCIII to M.D. MINECO Ramón y Cajal (#RYC-2016-20414), AGAUR (#2017 SGR 926), (#RTI2018-094887-B-I00) and Fondo Europeo de Desarrollo Regional (FEDER) to M.N.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Behavioral sensitization and cellular responses to psychostimulants are reduced in D2R knockout mice.

  • Solís, O.
  • García-Sanz, Patricia
  • Martín, A. B.
  • Granado, Noelia
  • Sanz-Magro, Adrián
  • Podlesniy, Petar
  • Trullas, Ramón
  • Murer, Mario Gustavo
  • Maldonado, Rafael
  • Moratalla, Rosario
Repeated cocaine exposure causes long-lasting neuroadaptations that involve alterations in cellular signaling and gene expression mediated by dopamine in different brain regions, such as the striatum. Previous studies have pointed out to the dopamine D1 receptor as one major player in psychostimulants-induced behavioral, cellular, and molecular changes. However, the role of other dopamine receptors has not been fully characterized. Here we used dopamine D2 receptor knockout (D2−/−) mice to explore the role of D2 receptor (D2R) in behavioral sensitization and its associated gene expression after acute and chronic cocaine and amphetamine administration. We also studied the impact of D2R elimination in D1R-mediated responses. We found that cocaine- and amphetamine-induced behavioral sensitization is deficient in D2−/− mice. The expression of dynorphin, primarily regulated by D1R and a marker of direct-pathway striatal neurons, is attenuated in naïve- and in cocaine- or amphetamine-treated D2−/− mice. Moreover, c-Fos expression observed in D2−/− mice was reduced in acutely but not in chronically treated animals. Interestingly, inactivation of D2R increased c-Fos expression in neurons of the striatopallidal pathway. Finally, elimination of D2R blunted the locomotor and striatal c-Fos response to the full D1 agonist SKF81297. In conclusion, D2R is critical for the development of behavioral sensitization and the associated gene expression, after cocaine administration, and it is required for the locomotor responses promoted by D1R activation., This work was supported by grants from the Spanish Ministries of Innovation, Science and Universities (SAF2016-78207-R and PCIN2015-098 to R. Moratalla, SAF2017-84060-R-AEI/FEDER-UE to R. Maldonado, and SAF2017-89791-R to P. Podlesniy and R. Trullas) and Health, Social Services and Equality (PNSD 2016/033 and CIBERNED CB06/05/0055 to R. Moratalla and RETICS/RTA, RD16/0017 to R.Maldonado.) and from the Ramón Areces Foundation (172275 and OTR02679) to R. Moratalla and ANPCYT (Agency for the Promotion of Science and Technology, Argentina), PICT 2013 1523 and 2015 3687 and by the University of Buenos Aires (UBACYT 2018) to M.G.M. and the Catalan Government (AGAUR, #ICREA Acadèmia-2015 and #2017-SGR-669) to R. Maldonado.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status

  • Mayneris-Perxachs, Jordi
  • Arnoriaga-Rodríguez, María
  • Luque-Córdoba, Diego
  • Priego-Capote, Feliciano
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Burokas, Aurelijus
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
[Background]: Gonadal steroid hormones have been suggested as the underlying mechanism responsible for the sexual dimorphism observed in metabolic diseases. Animal studies have also evidenced a causal role of the gut microbiome and metabolic health. However, the role of sexual dimorphism in the gut microbiota and the potential role of the microbiome in influencing sex steroid hormones and shaping sexually dimorphic susceptibility to disease have been largely overlooked. Although there is some evidence of sex-specific differences in the gut microbiota diversity, composition, and functionality, the results are inconsistent. Importantly, most of these studies have not taken into account the gonadal steroid status. Therefore, we investigated the gut microbiome composition and functionality in relation to sex, menopausal status, and circulating sex steroids., [Results]: No significant differences were found in alpha diversity indices among pre- and post-menopausal women and men, but beta diversity differed among groups. The gut microbiota from post-menopausal women was more similar to men than to pre-menopausal women. Metagenome functional analyses revealed no significant differences between post-menopausal women and men. Gonadal steroids were specifically associated with these differences. Hence, the gut microbiota of pre-menopausal women was more enriched in genes from the steroid biosynthesis and degradation pathways, with the former having the strongest fold change among all associated pathways. Microbial steroid pathways also had significant associations with the plasma levels of testosterone and progesterone. In addition, a specific microbiome signature was able to predict the circulating testosterone levels at baseline and after 1-year follow-up. In addition, this microbiome signature could be transmitted from humans to antibiotic-induced microbiome-depleted male mice, being able to predict donor’s testosterone levels 4 weeks later, implying that the microbiota profile of the recipient mouse was influenced by the donor’s gender. Finally, obesity eliminated most of the differences observed among non-obese pre-menopausal women, post-menopausal women, and men in the gut microbiota composition (Bray-Curtis and weighted unifrac beta diversity), functionality, and the gonadal steroid status., [Conclusions]: The present findings evidence clear differences in the gut microbial composition and functionality between men and women, which is eliminated by both menopausal and obesity status. We also reveal a tight link between the gut microbiota composition and the circulating levels of gonadal steroids, particularly testosterone., This work was partially supported by research grants FIS (PI15/01934) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and AEI-SAF2017-84060-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain, and also by European Commission (FP7, NeuroPain #2013-602891; #H2020-SC1-2019-2-RTD-848099 (PAINFACT)), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Fondo Europeo de Desarrollo Regional (FEDER) through the Programa Interreg V-A España-Francia-Andorra (POCTEFA 2014-2020), and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). María Arnoriaga Rodríguez is funded by a predoctoral Río Hortega contract (CM19/00190, co-funded by European Social Fund “Investing in your future”) from the Instituto de Salud Carlos III, Spain. Jordi Mayneris-Perxachs is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

  • Arnoriaga-Rodríguez, María
  • Mayneris-Perxachs, Jordi
  • Contreras-Rodríguez, Oren
  • Burokas, Aurelijus
  • Ortega-Sanchez, Juan-Antonio
  • Blasco, Gerard
  • Coll, Clàudia
  • Biarnés, Carles
  • Castells-Nobau, Anna
  • Puig, Josep
  • Garre-Olmo, Josep
  • Ramos, Rafel
  • Pedraza, Salvador
  • Brugada, Ramon
  • Vilanova, Joan C.
  • Serena, Joaquín
  • Barretina, Jordi
  • Gich, Jordi
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Fernández-Real, Xavier
  • Ramió-Torrentà, Lluís
  • Pamplona, Reinald
  • Sol, Joaquim
  • Jové, Mariona
  • Ricart, Wifredo
  • Portero-Otín, Manuel
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
Gut: first published., [Background]: Inhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits., [Methods]: We studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics., [Results]: An interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (thyX,dut, exodeoxyribonuclease V), and the anterior cingulate cortex volume were associated with IC, cross-sectionally and longitudinally. FMT from individuals with obesity led to alterations in mice reversal learning. In an independent FMT experiment, human donor’s bacterial functions related to IC deficits were associated with mPFC expression of one-carbon metabolism-related genes of recipient’s mice., [Conclusion]: These results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts., This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and #AEI-SAF2017-84060-R-FEDER from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Catalan Goverment (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [STL002/16/00250]; the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A SpainFrance-Andorra programme (POCTEFA 2014-2020). MA-R is funded by a predoctoral Río Hortega contract from the Instituto de Salud Carlos III (ISCIII, CM19/00190), co-funded by the European Social Fund “Investing in your future”. OC-R is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP20/00165), co-funded by the Europeran Social Fund "Investing in your future". JM-P is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. JS is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. MJ is a professor under the “Serra Hunter” programme (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Obesity impairs short-term and working memory through gut microbial metabolism of aromatic amino acids

  • Arnoriaga-Rodríguez, María
  • Mayneris-Perxachs, Jordi
  • Burokas, Aurelijus
  • Contreras-Rodríguez, Oren
  • Blasco, Gerard
  • Coll, Clàudia
  • Biarnés, Carles
  • Miranda-Olivos, Romina
  • Latorre, Jèssica
  • Moreno-Navarrete, José Maria
  • Castells-Nobau, Anna
  • Sabater-Masdeu, Mònica
  • Palomo-Buitrago, María Encarnación
  • Puig, Josep
  • Pedraza, Salvador
  • Gich, Jordi
  • Pérez-Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Fernández-Real, Xavier
  • Ramió-Torrentà, Lluís
  • Pamplona, Reinald
  • Sol, Joaquim
  • Jové, Mariona
  • Portero-Otín, Manuel
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
The gut microbiome has been linked to fear extinction learning in animal models. Here, we aimed to explore the gut microbiome and memory domains according to obesity status. A specific microbiome profile associated with short-term memory, working memory, and the volume of the hippocampus and frontal regions of the brain differentially in human subjects with and without obesity. Plasma and fecal levels of aromatic amino acids, their catabolites, and vegetable-derived compounds were longitudinally associated with short-term and working memory. Functionally, microbiota transplantation from human subjects with obesity led to decreased memory scores in mice, aligning this trait from humans with that of recipient mice. RNA sequencing of the medial prefrontal cortex of mice revealed that short-term memory associated with aromatic amino acid pathways, inflammatory genes, and clusters of bacterial species. These results highlight the potential therapeutic value of targeting the gut microbiota for memory impairment, specifically in subjects with obesity., This work was partially supported by FIS research grants (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III, Spain; SAF2015-65878-R and #AEI-SAF2017-84060-R FEDER from Ministry of Economy and Competitiveness; Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds; European Commission (FP7, NeuroPain #2013-602891); the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015); the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020); the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00); the Catalan Government (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [SLT002/16/00250]); the European Regional Development Fund (project no. 1.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and Fondo Europeo de Desarrollo Regional (FEDER) through the Programa Interreg V-A España-Francia-Andorra (POCTEFA 2014-2020). M.A.-R. is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190, co-funded by European Social Fund “Investing in your future”). O.C.-R. is funded by a postdoctoral “PERIS” contract (SLT006/17/00236) from the Catalan Government, 2017, Spain. J.M.-P. is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII, CP18/00009, co-funded by the European Social Fund “Investing in your future”). J.S. is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. M.J. is a professor under the Serra Hunter program (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of the endocannabinoid system in drug addiction

  • Manzanares, Jorge
  • Cabañero, David
  • Puente, Nagore
  • García-Gutiérrez, María Salud
  • Grandes, Pedro
  • Maldonado, Rafael
Drug addiction is a chronic relapsing disorder that produces a dramatic global health burden worldwide. Not effective treatment of drug addiction is currently available probably due to the difficulties to find an appropriate target to manage this complex disease raising the needs for further identification of novel therapeutic approaches. The endocannabinoid system has been found to play a crucial role in the neurobiological substrate underlying drug addiction. Endocannabinoids and cannabinoid receptors are widely expressed in the main areas of the mesocorticolimbic system that participate in the initiation and maintenance of drug consumption and in the development of compulsion and loss of behavioral control occurring during drug addiction. The identification of the important role played by CB1 cannabinoid receptors in drug addiction encouraged the possible used of an early commercialized CB1 receptor antagonist for treating drug addiction. However, the incidence of serious psychiatric adverse events leaded to the sudden withdrawal from the market of this CB1 antagonist and all the research programs developed by pharmaceutical companies to obtain new CB1 antagonists were stopped. Currently, new research strategies are under development to target the endocannabinoid system for drug addiction avoiding these side effects, which include allosteric negative modulators of CB1 receptors and compounds targeting CB2 receptors. Recent studies showing the potential role of CB2 receptors in the addictive properties of different drugs of abuse have open a promising research opportunity to develop novel possible therapeutic approaches., We acknowledge the financial support of the Spanish MINECO (#SAF2017-84060-R-AEI/FEDER-UE), Instituto de Salud Carlos III-RETICS (##RD16/0017/0020), Ministerio de Sanidad, Servicios Sociales e Igualdad-Plan Nacional Sobre Drogas (#PNSD-2017I068), and the Generalitat de Catalunya-AGAUR ((#2017-SGR-669 and #ICREA Acadèmia2015) and the European Commission-DG RTD (#FP7-HEALTH-F2-2013-602891-NeuroPain) to RM. FEDER funding support is also acknowledged. This work was supported by Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU) (RD16/0017/0012), The Basque Government (BCG IT764-13) and MINECO/FEDER, UE (SAF2015-65034-R) to PG. This research was supported by Instituto de Salud Carlos III (RETICS, RD12/0028/0019, RD16/0017/0014 and RD06/0001/1004), Plan Nacional Sobre Drogas (PNSD 2016/016 and 2007/061), Ministerio de Economía y Competitividad (FIS, PI14/00438) and Ministerio de Ciencia e Innovación (SAF2008-01106) to JM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulėnaitė, Solveiga
  • García-Blanco, Alejandra
  • Mayneris-Perxachs, Jordi
  • Domingo-Rodríguez, Laura
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus
  • Espinosa-Carrasco, Jose
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández-Real, Jose Manuel
  • Maldonado, Rafael
  • Martín-García, Elena
Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish ’Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)’ (PID2020- 120029GB-I00/ MICIU/ AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ’Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ’Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ’La Marató de TV3’ #20221830, ’ICREA-Acadèmia’ (#2015) and the Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073- 2A to EM-G. Spanish-MINECO (#SAF2017-84060- R- AEI/ FEDER-UE) to LD-R, Spanish ’Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968- B- 100, #PID2021-127776OB- I00), ’AGAUR-Generalitat de Catalunya’ (#2017-SGR- 738, #2021-SGR- 01093) and Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT- K- 718- 03- 0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), ’La Marató de TV3’ #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB- I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the ’CERCA Programme/Generalitat de Catalunya’., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Operant self-medication for assessment of spontaneous pain relief and drug abuse liability in mouse models of chronic pain

  • Cabañero Ferri, David
  • Álvarez-Pérez, Beltrán
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The search for safe and efficient chronic pain treatments is dampened by the lack of reliable models that faithfully reproduce current pharmacological treatments for chronic spontaneous pain in humans. Preclinical models often assess the antinociceptive efficacy of non-contingent pharmacological treatments evaluated in the short-term. Here, we provide a protocol of contingent operant self-medication in mice, which allows the estimation of spontaneous pain relief and drug abuse liability in models of persistent pain. This paradigm requires preliminary habituation and animal handling, followed by training of mice in operant conditioning boxes, to allow subsequent analgesic drug self-administration. After the initial acquisition of food-maintained operant behavior, a chronic pain sensitization is induced. Posterior intravenous jugular catheterization and coupling of operant conditioning boxes to perfusion pumps allow quantification of operant responding for intravenous drug self-administration. All mice show an initial operant drug self-administration behavior associated with the previous food-maintained operant training. This initial operant responding is extinguished after administration of ineffective treatments, but continues when the compounds have analgesic efficacy or intrinsic reinforcing properties. The identification of a significant drug self-administration selectively expressed in mice exposed to the chronic pain condition is indicative of analgesic drug effects, whereas persistent self-administration in control mice is indicative of abuse liability. The present protocol provides the behavioral and surgical procedures needed to assess spontaneous pain relief and potential for abuse of pharmacological treatments, through contingent analgesic self-medication in mice., This work was supported by the European Comission [NeuroPain, FP7-602891-2], the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848068 [QSPainRelief, H2020-SC1-2019-2-RTD-848068], the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R- AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD- 2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) and Plan Nacional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2019I006) to E.M-G. The methodology described was previously used in Bura et al. (2013, 2018) and Cabañero et al. (2020, doi: 10.7554/eLife.55582). Authors also want to thank E. Senabre and R. Martín for their critics and technical support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2

  • Martínez-Torres, Sara
  • Cutando Ruiz, Laura, 1985-
  • Pastor, Antonio
  • Kato, Ako
  • Sakimura, Kenji
  • Torre Fornell, Rafael de la
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Kano, Masanobu
  • Ozaita Mintegui, Andrés, 1969-
Monoacylglycerol lipase (MAGL) is the main enzyme implicated in the degradation of the most abundant endocannabinoid in the brain, 2-arachidonoylglycerol (2-AG), producing arachidonic acid (AA) and glycerol. MAGL pharmacological inhibition with JZL184 or genetic deletion results in an exacerbated 2-AG signaling and reduced synthesis of prostaglandins (PGs), due to the reduced AA precursor levels. We found that acute JZL184 administration, previously described to exert anti-inflammatory effects, and MAGL knockout (KO) mice display cerebellar, but not hippocampal, microglial reactivity, accompanied with increased expression of the mRNA levels of neuroinflammatory markers, such as cyclooxygenase-2 (COX-2). Notably, this neuroinflammatory phenotype correlated with relevant motor coordination impairment in the beam-walking and the footprint tests. Treatment with the COX-2 inhibitor NS398 during 5 days prevented the deficits in cerebellar function and the cerebellar microglia reactivity in MAGL KO, without affecting hippocampal reactivity. Altogether, this study reveals the brain region-specific response to MAGL inhibition, with an important role of COX-2 in the cerebellar deficits associated, which should be taken into account for the use of MAGL inhibitors as anti-inflammatory drugs., This work was supported by the Ministerio de Economía, Innovación y Competitividad (MINECO) [#BFU2015-68568-P to A.O., #SAF2017-84060-R to R.M.]; the Instituto de Salud Carlos III [#RD16/0017/0020 to R.M.]; the Generalitat de Catalunya [2017SGR-669 to R.M.]; the ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M.; Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO [#MDM-2014-0370]; PLAN E (Plan Español para el Estímulo de la Economía y el Empleo); Fondation pour la Recherche Médicale to E.V and FEDER funding is also acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Anti-inflammatory agents for smoking cessation? Focus on cognitive deficits associated with nicotine withdrawal in male mice

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Grande, María T.
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Nicotine withdrawal is associated with cognitive deficits including attention, working memory, and episodic memory impairments. These cognitive deficits are a hallmark of nicotine abstinence which could be targeted in order to prevent smoking relapse. The underlying mechanisms, however, are poorly understood. In this study, memory impairment was observed in mice 4 days after the precipitation of nicotine withdrawal by the nicotinic antagonist mecamylamine. The presence of cognitive deficits correlated with microglial activation in the hippocampus and the prefrontal cortex. Moreover, an increased expression of neuroinflammatory markers including IL1β, TNFα and IFNγ was found in both memory-related brain regions. Notably, flow cytometric analysis also revealed an enhancement of TNFα and IFNγ plasmatic levels at the same time point during nicotine withdrawal. Impaired neurogenesis, as shown by reduction in the expression of the endogenous cell proliferation marker Ki67 and the early neuron marker doublecortin, was also associated with nicotine abstinence. Treatment with the non-psychoactive cannabinoid cannabidiol abolished memory impairment of nicotine withdrawal and microglia reactivity, reduced the expression of IL1β and IFNγ in the hippocampus and the prefrontal cortex, respectively, and normalized Ki67 levels. The nonsteroidal anti-inflammatory drug indomethacin also prevented cognitive deficits and microglial reactivity during withdrawal. These data underline the usefulness of anti-inflammatory agents to improve cognitive performance during early nicotine abstinence., This work was supported by “Plan Nacional sobre Drogas”(#2014I019) and “Ministerio de Economía y Competitividad” MINECO/FEDER, UE (SAF2017-85299-R) to FB, the “Generalitat deCatalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM. Rocio Saraviais a recipient of a predoctoral fellowship from the “Instituto de Salud Carlos III”
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Why mu-opioid agonists have less analgesic efficacy in neuropathic pain?

  • Martínez-Navarro, Miriam
  • Maldonado, Rafael, 1961-
  • Baños i Díez, Josep Eladi
Injury to peripheral nerves often leads to abnormal pain states (hyperalgesia, allodynia and spontaneous pain), which can remain long after the injury heals. Although opioid agonists remain the gold standard for the treatment of moderate to severe pain, they show reduced efficacy against neuropathic pain. In addition to analgesia, opioid use is also associated with hyperalgesia and analgesia tolerance, whose underlying mechanisms share some commonalities with nerve injury-induced hypersensitivity. Here, we reviewed up-to-day research exploring the contribution of mu-opioid receptor (MOR) on the pathophysiology of neuropathic pain and on analgesic opioid actions under these conditions. We focused on the specific contributions of MOR populations at peripheral, spinal and supraspinal level. Moreover, evidences of neuroplastic changes that may underlie the low efficacy of MOR agonists under neuropathic pain conditions are reviewed and discussed. Sensitization processes leading to pain hypersensitivity, molecular changes in signalling pathways triggered by MOR and glial activation are some of these mechanisms elicited by both nerve injury and opioid exposure. Nerve injury-induced pain hypersensitivity might be masking the initial analgesic effects of opioid agonists, and alternatively, sustained opioid treatment to individuals already suffering from neuropathic pain could aggravate their pathophysiological state. Finally, some combined therapies that can increase opioid analgesic effectiveness in neuropathic pain treatment are highlighted. SIGNIFICANCE: This review provides evidence of the low benefit of opioid monotherapy in neuropathic pain and analyses the reasons of this reduced effectiveness. Opioid agonists along with drugs targeted to block the sensitization processes induced by MOR stimulation might result in a better management of neuropathic pain., We acknowledge the financial support of the European Commission FP7. Grant Number: #HEALTH‐F2‐2013‐602891; Spanish Ministry of Science, Innovation and Universities. Grant Number: #SAF2017‐84060‐R‐AEI/FEDER‐UE; Instituto de Salud Carlos III. Grant Number: RETICS/RTA #RD16/0017; Catalan Government AGAUR. Grant Numbers: #ICREA Acadèmia‐2015, #2017‐SGR‐669; Spanish MECD
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Surgical induction of endometriosis in female mice

  • Escudero Lara, Alejandra, 1992-
  • Cabañero Ferri, David
  • Maldonado, Rafael, 1961-
Endometriosis is a common gynecological disease characterized by the presence of endometrial tissue outside the uterine cavity. It is frequently associated with pain, infertility and a reduced quality of life, and it lacks adequate treatment. Several rodent models of endometriosis have been developed through heterologous and homologous transplantation of endometrial tissue into the abdominal compartment. Here we describe a surgical procedure to generate a syngeneic model of endometriosis in immunocompetent mice with intact uterine and ovarian tissues. In this model, four uterine fragments from a donor mouse at diestrus are sutured to the abdominal wall of a recipient mouse. One month after surgeries, endometrial implants develop into cysts with glandular epithelium and stroma, mimicking the endometriotic lesions observed in women with endometriosis. Therefore, this mouse model provides a valuable tool to study the pathophysiology of endometriosis and the efficacy of potential treatments., “Instituto de Salud Carlos III”, “Redes temáticas de investigación cooperativa en salud–Red de trastornos adictivos” (#RD16/0017/0020), “Ministerio de Ciencia, Innovación y Universidades”, MCIU (#SAF2017-84060-R-AEI/FEDER-UE), “Generalitat de Catalunya- Agència de Gestió d'Ajuts Universitaris i de Recerca-AGAUR" (#2017-SGR-669 and #ICREA Acadèmia2015) to R.M. are acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

  • Navarro Romero, Alba, 1990-
  • Galera López, Lorena, 1993-
  • Ortiz Romero, Paula, 1994-
  • Llorente-Ovejero, Alberto
  • Los Reyes-Ramírez, Lucía de
  • Bengoetxea de Tena, Iker
  • Garcia-Elias Heras, Anna
  • Mas Stachurska, Aleksandra
  • Reixachs i Solé, Marina
  • Pastor, Antonio
  • Torre Fornell, Rafael de la
  • Maldonado, Rafael, 1961-
  • Benito Villabriga, Begoña
  • Eyras Jiménez, Eduardo
  • Rodríguez-Puertas, Rafael
  • Campuzano Uceda, María Victoria
  • Ozaita Mintegui, Andrés, 1969-
Williams-Beuren syndrome (WBS) is a rare genetic multisystemic disorder characterized by mild-to-moderate intellectual disability and hypersocial phenotype, while the most life-threatening features are cardiovascular abnormalities. Nowadays, there are no pharmacological treatments to directly ameliorate the main traits of WBS. The endocannabinoid system (ECS), given its relevance for both cognitive and cardiovascular function, could be a potential druggable target in this syndrome. We analyzed the components of the ECS in the complete deletion (CD) mouse model of WBS and assessed the impact of its pharmacological modulation in key phenotypes relevant for WBS. CD mice showed the characteristic hypersociable phenotype with no preference for social novelty and poor short-term object-recognition performance. Brain cannabinoid type-1 receptor (CB1R) in CD male mice showed alterations in density and coupling with no detectable change in main endocannabinoids. Endocannabinoid signaling modulation with subchronic (10 days) JZL184, a selective inhibitor of monoacylglycerol lipase, specifically normalized the social and cognitive phenotype of CD mice. Notably, JZL184 treatment improved cardiovascular function and restored gene expression patterns in cardiac tissue. These results reveal the modulation of the ECS as a promising novel therapeutic approach to improve key phenotypic alterations in WBS., This study was supported by Ministerio de Economía, Innovación y Competitividad (MINECO), Spain #RTI2018-099282-B-I00B to A.O., #SAF2017-84060-R to R.M.; Generalitat de Catalunya, Spain (2017SGR-669 to R.M.); Ministerio de Ciencia e Innovación (SAF2016-78508-R; AEI/MINEICO/FEDER, UE) to VC. Basque Government IT1454-22 to the 'Neurochemistry and Neurodegeneration' consolidated research group to R R-P. Instituto de Salud Carlos III (PI20/00153, co-funded by the European Union [ERDF 'A way to make Europe']) to R R-P. ICREA (Institució Catalana de Recerca i Estudis Avançats, Spain) Academia to A.O. and R.M. Grant 'Unidad de Excelencia María de Maeztu', funded by the MINECO (#MDM-2014-0370); IPEP MdM 2017 to A.O. and E.E. FEDER, European Commission funding is also acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Luque-Córdoba, Diego
  • Priego-Capote, Feliciano
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Burokas, Aurelijus, 1982-
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Background: Gonadal steroid hormones have been suggested as the underlying mechanism responsible for the sexual dimorphism observed in metabolic diseases. Animal studies have also evidenced a causal role of the gut microbiome and metabolic health. However, the role of sexual dimorphism in the gut microbiota and the potential role of the microbiome in influencing sex steroid hormones and shaping sexually dimorphic susceptibility to disease have been largely overlooked. Although there is some evidence of sex-specific differences in the gut microbiota diversity, composition, and functionality, the results are inconsistent. Importantly, most of these studies have not taken into account the gonadal steroid status. Therefore, we investigated the gut microbiome composition and functionality in relation to sex, menopausal status, and circulating sex steroids. Results: No significant differences were found in alpha diversity indices among pre- and post-menopausal women and men, but beta diversity differed among groups. The gut microbiota from post-menopausal women was more similar to men than to pre-menopausal women. Metagenome functional analyses revealed no significant differences between post-menopausal women and men. Gonadal steroids were specifically associated with these differences. Hence, the gut microbiota of pre-menopausal women was more enriched in genes from the steroid biosynthesis and degradation pathways, with the former having the strongest fold change among all associated pathways. Microbial steroid pathways also had significant associations with the plasma levels of testosterone and progesterone. In addition, a specific microbiome signature was able to predict the circulating testosterone levels at baseline and after 1-year follow-up. In addition, this microbiome signature could be transmitted from humans to antibiotic-induced microbiome-depleted male mice, being able to predict donor's testosterone levels 4 weeks later, implying that the microbiota profile of the recipient mouse was influenced by the donor's gender. Finally, obesity eliminated most of the differences observed among non-obese pre-menopausal women, post-menopausal women, and men in the gut microbiota composition (Bray-Curtis and weighted unifrac beta diversity), functionality, and the gonadal steroid status. Conclusions: The present findings evidence clear differences in the gut microbial composition and functionality between men and women, which is eliminated by both menopausal and obesity status. We also reveal a tight link between the gut microbiota composition and the circulating levels of gonadal steroids, particularly testosterone. Video Abstract., This work was partially supported by research grants FIS (PI15/01934) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and AEI-SAF2017-84060-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain, and also by European Commission (FP7, NeuroPain #2013-602891; #H2020-SC1-2019-2-RTD-848099 (PAINFACT)), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Fondo Europeo de Desarrollo Regional (FEDER) through the Programa Interreg V-A España-Francia-Andorra (POCTEFA 2014-2020), and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). María Arnoriaga Rodríguez is funded by a predoctoral Río Hortega contract (CM19/00190, co-funded by European Social Fund “Investing in your future”) from the Instituto de Salud Carlos III, Spain. Jordi Mayneris-Perxachs is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Influence of behavioral traits in the inter-individual variability of nociceptive, emotional and cognitive manifestations of neuropathic pain

  • Martínez-Navarro, Miriam
  • Lara Mayorga, Itzel Montserrat, 1982-
  • Negrete Buela, Roger
  • Bilecki, Wiktor
  • Wawrzczak-Bargiela, Agnieszka
  • Gonçalves, Leonor
  • Dickenson, Anthony Henry
  • Przewlocki, Ryszard
  • Baños i Díez, Josep Eladi
  • Maldonado, Rafael, 1961-
Neuropathic pain is a complex disorder associated with emotional and cognitive deficits that may impair nociceptive manifestations. There is high inter-individual variability in the manifestations of human neuropathic pain, which largely depends on personality traits. We aim to identify the influence of different behavioral traits in the interindividual vulnerability to neuropathic pain manifestations using behavioral, electrophysiological and genetic approaches. We first selected mice with extreme social and emotional traits and look for correlation with the spontaneous neuronal activity in the central amygdala. Neuropathic pain was induced to these mice to evaluate the influence of behavioral traits on nociceptive manifestations and gene expression profiles in the amygdala. Our results show an association of the spontaneous central amygdala neuronal activity with the sociability behavior. We demonstrate that low sociable, high anxious and low depressive phenotypes develop enhanced nociceptive hypersensitivity after nerve injury. However, greater emotional alterations and cognitive impairment are observed in high sociable, anxious-like and depressive-like mice, indicating that nociceptive, emotional and cognitive manifestations of neuropathic pain do not correlate with each other. Gene analyses identify high Pdyn and Il6 levels in the amygdala as indicative of enhanced nociceptive hypersensitivity and reveal an association between high Gadd45 expression and attenuated emotional and cognitive manifestations of neuropathic pain., This work was supported by the European Commission, FP7 (#HEALTH-F2-2013- 602891), the Spanish Ministerio de Economía y Competitividad MINECO (#SAF2014-59648-P and #SAF2017-84060-R), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023) and the Generalitat de Catalunya, AGAUR (#2014-SGR-1547) and Polish Ministry of Science and Education (#3070/7.PR/2014/2). M.M.N. and R.N. are recipients of a predoctoral fellowship from the Spanish Ministerio de Educación, Cultura y Deporte (MECD). I.M.L.M. is recipient of a predoctoral fellowship from the Mexican Consejo Nacional de Ciencia y Tecnología (CONACyT). FEDER partial funding is also acknowledged. W.B. and A.B. are recipients of Polish Ministry of Science and Education and European Commission grants
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice

  • Flores de los Heros, África, 1985-
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Rationale: Cannabis use is typically initiated during adolescence, and different studies suggest that adolescent cannabinoid exposure may increase the risk for drug addiction in adulthood. Objectives: This study investigated the effects of adolescent exposure to the main psychoactive component of cannabis, ∆9-tetrahydrocannabinol (THC), in the reinforcing properties of nicotine in adult male mice. Possible alterations in relapse to nicotine-seeking behaviour in adult animals due to THC adolescent exposure were also evaluated. Methods: Adolescent mice were exposed to escalating doses of THC from PND35 to PND49. When mice reached adulthood (PND70), surgical procedures were applied for further behavioural evaluation. Nicotine self-administration sessions were conducted consecutively for 10 days. Following extinction, mice were tested for cue- and stress-induced reinstatement of nicotine-seeking behaviour. Results: Adolescent THC treatment did not modify acquisition and extinction of nicotine self-administration in adulthood. Moreover, THC exposure did not alter relapse to nicotine seeking induced by stress or nicotine-associated cues. Conclusions: These results suggest that a history of exposure to THC during adolescence under these particular conditions does not modify the reinforcing effects and seeking behaviour of nicotine in the adult period., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the “Generalitat de Catalunya-AGAUR” (#2014-SGR-1547), ICREA-Acadèmia (2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cell-type- and region-specific modulation of cocaine seeking by micro-RNA-1 in striatal projection neurons

  • Forget, Benoit
  • Martín García, Elena, 1975-
  • Godino, Arthur
  • Domingo Rodriguez, Laura, 1992-
  • Kappes, Vincent
  • Poirier, Pierre
  • Andrianarivelo, Andry
  • Senabre, Eric
  • Allichon, Marie-Charlotte
  • Marias, Mélanie
  • Vanhoutte, Peter
  • Girault, Jean-Antoine
  • Maldonado, Rafael, 1961-
  • Caboche, Jocelyne
The persistent and experience-dependent nature of drug addiction may result in part from epigenetic alterations, including non-coding micro-RNAs (miRNAs), which are both critical for neuronal function and modulated by cocaine in the striatum. Two major striatal cell populations, the striato-nigral and striato-pallidal projection neurons, express, respectively, the D1 (D1-SPNs) and D2 (D2-SPNs) dopamine receptor, and display distinct but complementary functions in drug-evoked responses. However, a cell-type-specific role for miRNAs action has yet to be clarified. Here, we evaluated the expression of a subset of miRNAs proposed to modulate cocaine effects in the nucleus accumbens (NAc) and dorsal striatum (DS) upon sustained cocaine exposure in mice and showed that these selected miRNAs were preferentially upregulated in the NAc. We focused on miR-1 considering the important role of some of its predicted mRNA targets, Fosb and Npas4, in the effects of cocaine. We validated these targets in vitro and in vivo. We explored the potential of miR-1 to regulate cocaine-induced behavior by overexpressing it in specific striatal cell populations. In DS D1-SPNs miR-1 overexpression downregulated Fosb and Npas4 and reduced cocaine-induced CPP reinstatement, but increased cue-induced cocaine seeking. In DS D2-SPNs miR-1 overexpression reduced the motivation to self-administer cocaine. Our results indicate a role of miR1 and its target genes, Fosb and Npas4, in these behaviors and highlight a precise cell-type- and region-specific modulatory role of miR-1, illustrating the importance of cell-specific investigations., This work was supported by Fondation pour la Recherche Médicale (DEQ20150734352 to JC), Centre National pour la Recherche Scientifique (CNRS, B.F., A.G., V.K., P.P., P.V., J.C.), Institut National pour la Santé et la Recherche Médicale (INSERM; B.F., A.G., V.K., P.P., P.V., J.-A.G., J.C.), Sorbonne Université, Faculté des Sciences et Ingénierie (B.F., A.G., V.K., P.P., P.V., J.-A.G., J.C.) Labex Biopsy Investissements d’Avenir, ANR-11-IDEX-0004-02 (B.F., A.G., V.K., P.P., P.V., J.-A.G., J.C.), the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE; E.M.-G., L.D.-R., R.M.), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023; E.M.-G., L.D.-R., R.M.), the Generalitat de Catalunya, AGAUR (#2017-SGR-669; E.M.-G., L.D.-R., R.M.), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) to E.M.-G. Fondation pour la Recherche Médicale (FRM#DPA20140629798) and ANR (ANR-16-CE16-0018) to J.A.G.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Protein kinase C-gamma knockout mice show impaired hippocampal short-term memory while preserved long-term memory

  • Gomis González, Maria, 1988-
  • Galera López, Lorena, 1993-
  • Ten-Blanco, Marc
  • Busquets Garcia, Arnau, 1985-
  • Cox, Thomas
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
The brain encodes, stores, and retrieves relevant information in the form of memories that are classified as short-term (STM) and long-term memories (LTM) depending on the interval between acquisition and retrieval. It is classically accepted that STM undergo a consolidation process to form LTM, but the molecular determinants involved are not well understood. Among the molecular components relevant for memory formation, we focused our attention on the protein kinase C (PKC) family of enzymes since they control key aspects of the synaptic plasticity and memory. Within the different PKC isoforms, PKC-gamma has been specifically associated with learning and memory since mice lacking this isoform (PKC-gamma KO mice) showed mild cognitive impairment and deficits in hippocampal synaptic plasticity. We now reveal that PKC-gamma KO mice present a severe impairment in hippocampal-dependent STM using different memory tests including the novel object-recognition and novel place-recognition, context fear conditioning and trace fear conditioning. In contrast, no differences between genotypes were observed in an amygdala-dependent test, the delay fear conditioning. Strikingly, all LTM tasks that could be assessed 24 h after acquisition were not perturbed in the KO mice. The analysis of c-Fos expression in several brain areas after trace fear conditioning acquisition showed a blunted response in the dentate gyrus of PKC-gamma KO mice compared with WT mice, but such differences between genotypes were absent when the amygdala or the prefrontal cortex were examined. In the hippocampus, PKC-gamma was found to translocate to the membrane after auditory trace, but not after delay fear conditioning. Together, these results indicate that PKC-gamma dysfunction affects specifically hippocampal-dependent STM performance and disclose PKC-gamma as a molecular player differentially involved in STM and LTM processes., This work was supported by the Ministerio de Economía, Innovación y Competitividad (MINECO) [#BFU2015-68568-P to A.O., #SAF2017-84060-R to R.M.]; the Instituto de Salud Carlos III [#RD16/0017/0020 to R.M.]; the Ministerio de Ciencia, Innovación y Universidades [# RTI2018-099282-B-I00 (AEI/FEDER/UE) to A.O.]; the Generalitat de Catalunya [2017SGR-669 to R.M.]; the ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M.; Grant “Unidad de Excelencia María de Maeztu,” funded by the MINECO [#MDM-2014-0370]; PLAN E (Plan Español para el Estímulo de la Economía y el Empleo). FEDER funding is also acknowledged.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood

  • Saravia Santos, Rocio, 1988-
  • Ten-Blanco, Marc
  • Julià Hernández, Marina
  • Gagliano, Humberto
  • Andero, Raül
  • Armario García, Antonio
  • Maldonado, Rafael, 1961-
  • Berrendero Díaz, Fernando, 1971-
Δ9-tetrahydrocannabinol (THC) consumption during adolescence is reported to be a risk factor for the appearance of psychiatric disorders later in life. The interaction between genetic or environmental events and cannabinoid exposure in the adolescent period can also contribute to exacerbate behavioural deficits in adulthood. Here we investigate the effects of THC treatment as well as the consequences of concomitant THC and stress exposure during adolescence in the extinction of fear memory in adult mice. Adolescent mice treated with THC and exposed to stress exhibit impaired cued fear extinction in adulthood. However, no effect was observed in animals exposed to these two factors separately. Notably, resistance to fear extinction was associated with decreased neuronal activity in the basolateral amygdala (BLA) and the infralimbic prefrontal cortex, suggesting a long-term dysregulation of the fear circuit. These changes in neuronal activation were paralleled with structural plasticity alterations. Indeed, an increase of immature dendritic spines in pyramidal neurons of the BLA was revealed in mice simultaneously exposed to THC and stress. Corticosterone levels were also enhanced after the cued fear conditioning session in the same experimental group. These results show that an interaction between cannabis exposure and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear., This work was supported by “Plan Nacional sobre Drogas” (#2014I019) and “Ministerio de Economía y Competitividad” (SAF2017-85299-R) to FB, the "Generalitat de Catalunya-AGAUR" (#2014-SGR-1547), ICREA-Acadèmia(2015) and “Ministerio de Economía y Competitividad” (#SAF2017-84060-R) to RM, NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MINECOSAF2016-76565-R and FEDER funds to RA, and “Ministerio de Economía y Competitividad” (SAF2014-53876R) and “Generalitat de Catalunya” (SGR 2014-1020) to AA
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Auricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model

  • Vázquez-Oliver, Anna
  • Brambilla Pisoni, Cecilia, 1993-
  • Domingo-Gainza, Mikel
  • Maldonado, Rafael, 1961-
  • Ivorra Cano, Antoni, 1974-
  • Ozaita Mintegui, Andrés, 1969-
Background: Vagus nerve stimulation (VNS) using non-invasive approaches have attracted great attention due to their anti-epileptic, anti-depressive and pro-cognitive effects. It has been proposed that auricular transcutaneous VNS (atVNS) could benefit intellectual disability disorders, but preclinical data supporting this idea is limited. Objective: To develop an atVNS device for mice and to test its efficacy on memory performance in naïve mice and in a mouse model for intellectual disability. Methods: Naïve outbreed CD-1 mice and a model for fragile X syndrome, the Fmr1 knockout (Fmr1KO), were used to assess the effect of atVNS in the novel object-recognition memory performance. Results: We found that atVNS significantly improves memory persistence in naïve mice. Notably, atVNS was efficacious in normalizing the object-recognition memory deficit in the Fmr1KO model. Conclusion: Our data show that atVNS improves memory persistence in naïve mice and in a model of intellectual disability and support further studies taking advantage of preclinical mouse models of cognitive disorders., This work was supported by a Predoctoral fellowship from Jerome Lejeune Foundation (Spanish division) (A.V.-O.) and from “la Caixa” Foundation (ID 100010434), LCF/BQ/IN18/11660012 and European Union’s Horizon 2020 research and innovation programme under the Marie Slodowska-Curie grant agreement No. 713673 (C.B.-P.). Ministerio de Economía, Innovación y Competitividad (MINECO) [#RTI2018-099282-B-I00 to A.O., #SAF2017-84060-R to R.M.]; the Instituto de Salud Carlos III [#RD16/0017/0020 to R.M.]; the Generalitat de Catalunya [2017SGR-669 to R.M.]; the ICREA (Institució Catalana de Recerca i Estudis Avançats) Acadèmia to A.O., A.I. and R.M.; Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO [#MDM-2014-0370]; PLAN E (Plan Español para el Estímulo de la Economía y el Empleo). FEDER (Fondo Europeo de Desarrollo Regional) funding is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain

  • Escudero-Lara, Alejandra
  • Argerich, Josep
  • Cabañero Ferri, David
  • Maldonado, Rafael, 1961-
Endometriosis is a chronic painful disease highly prevalent in women that is defined by growth of endometrial tissue outside the uterine cavity and lacks adequate treatment. Medical use of cannabis derivatives is a current hot topic and it is unknown whether phytocannabinoids may modify endometriosis symptoms and development. Here we evaluate the effects of repeated exposure to Δ9-tetrahydrocannabinol (THC) in a mouse model of surgically-induced endometriosis. In this model, female mice develop mechanical hypersensitivity in the caudal abdomen, mild anxiety-like behavior and substantial memory deficits associated with the presence of extrauterine endometrial cysts. Interestingly, daily treatments with THC (2 mg/kg) alleviate mechanical hypersensitivity and pain unpleasantness, modify uterine innervation and restore cognitive function without altering the anxiogenic phenotype. Strikingly, THC also inhibits the development of endometrial cysts. These data highlight the interest of scheduled clinical trials designed to investigate possible benefits of THC for women with endometriosis., Funding: “Instituto de Salud Carlos III”, “Redes temáticas de investigación cooperativa en salud – Red de trastornos adictivos” (#RD16/0017/0020), “Ministerio de Ciencia, Innovación y Universidades”, MCIU (#SAF2017-84060-R-AEI/FEDER-UE), “Generalitat de Catalunya - Agència de Gestió d'Ajuts Universitaris i de Recerca-AGAUR" (#2017-SGR422 669 and #ICREA Acadèmia2015) to R.M. are acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

  • Arnoriaga Rodríguez, María
  • Burokas, Aurelijus, 1982-
  • Ortega Sánchez, Juan Antonio
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Background: Inhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits. Methods: We studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics. Results: An interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (thyX,dut, exodeoxyribonuclease V), and the anterior cingulate cortex volume were associated with IC, cross-sectionally and longitudinally. FMT from individuals with obesity led to alterations in mice reversal learning. In an independent FMT experiment, human donor's bacterial functions related to IC deficits were associated with mPFC expression of one-carbon metabolism-related genes of recipient's mice. Conclusion: These results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts., This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015-65878-R and #AEI-SAF2017-84060-R-FEDER from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Catalan Goverment (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [STL002/16/00250]; the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). MA-R is funded by a predoctoral Río Hortega contract from the Instituto de Salud Carlos III (ISCIII, CM19/00190), co-funded by the European Social Fund “Investing in your future”. OC-R is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP20/00165), co-funded by the Europeran Social Fund "Investing in your future". JM-P is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. JS is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. MJ is a professor under the “Serra Hunter” programme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Role of the endocannabinoid system in drug addiction

  • Manzanares, Jorge
  • Cabañero Ferri, David
  • Puente, Nagore
  • García-Gutiérrez, María S.
  • Grandes, Pedro
  • Maldonado, Rafael, 1961-
Drug addiction is a chronic relapsing disorder that produces a dramaticglobal health burden worldwide. Not effective treatment of drug addiction is currently available probably due to the difficulties to find an appropriate target to manage this complex disease raising the needs for further identification of novel therapeutic approaches. The endocannabinoid system has been found to play a crucial role in the neurobiological substrate underlying drug addiction. Endocannabinoids and cannabinoid receptors are widely expressed in the main areas of the mesocorticolimbic system that participate in the initiation and maintenance of drug consumption and in the development of compulsion and loss of behavioral control occurring during drug addiction. The identification of the important role played by CB1 cannabinoid receptors in drug addiction encouraged the possible used of an early commercialized CB1 receptor antagonist for treating drug addiction. However, the incidence of serious psychiatric adverse events leaded to the sudden withdrawal from the market of this CB1 antagonist and all the research programs developed by pharmaceutical companies to obtain new CB1 antagonists were stopped. Currently, new research strategies are under development to target the endocannabinoid system for drug addiction avoiding these side effects, which include allosteric negative modulators of CB1 receptors and compounds targeting CB2 receptors. Recent studies showing the potential role of CB2 receptors in the addictive properties of different drugs of abuse have open a promising research opportunity to develop novel possible therapeutic approaches., We acknowledge the financial support of the Spanish MINECO (#SAF2017-84060-R-AEI/FEDER-UE), Instituto de Salud Carlos III-RETICS(##RD16/0017/0020), Ministerio de Sanidad, Servicios Sociales e Igualdad-Plan Nacional Sobre Drogas (#PNSD-2017I068), and the Generalitat de Catalunya-AGAUR ((#2017-SGR-669 and #ICREA Acadèmia2015) and the European Commission-DG RTD (#FP7-HEALTH-F2-2013-602891-NeuroPain) to RM. FEDER funding support is also acknowledged. This work was supported by Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU) (RD16/0017/0012), The Basque Government (BCG IT764-13) and MINECO/FEDER, UE(SAF2015-65034-R) to PG. This research was supported by Instituto de Salud Carlos III (RETICS, RD12/0028/0019, RD16/0017/0014 and RD06/0001/1004), Plan Nacional Sobre Drogas (PNSD 2016/016 and 2007/061), Ministerio de Economía y Competitividad (FIS, PI14/00438) and Ministerio de Ciencia e Innovación (SAF2008-01106) to JM
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Delta9-tetrahydrocannabinol modulates the proteasome system in the brain

  • Salgado Mendialdúa, Victòria
  • Aguirre Plans, Joaquim, 1993-
  • Guney, Emre
  • Reig-Viader, Rita
  • Maldonado, Rafael, 1961-
  • Bayés, Angels
  • Oliva Miguel, Baldomero
  • Ozaita Mintegui, Andrés, 1969-
Cannabis is the most consumed illicit drug worldwide. Its principal psychoactive component, Δ9-tetrahydrocannabinol (THC), affects multiple brain functions, including cognitive performance, by modulating cannabinoid type-1 (CB1) receptors. These receptors are strongly enriched in presynaptic terminals, where they modulate neurotransmitter release. We analyzed, through a proteomic screening of hippocampal synaptosomal fractions, those proteins and pathways modulated 3 h after a single administration of an amnesic dose of THC (10 mg/kg, i.p.). Using an isobaric labeling approach, we identified 2040 proteins, 1911 of them previously reported in synaptic proteomes, confirming the synaptic content enrichment of the samples. Initial analysis revealed a significant alteration of 122 proteins, where 42 increased and 80 decreased their expression. Gene set enrichment analysis indicated an over-representation of mitochondrial associated functions and cellular metabolic processes. A second analysis focusing on extreme changes revealed 28 proteins with altered expression after THC treatment, 15 of them up-regulated and 13 down-regulated. Using a network topology-based scoring algorithm we identified those proteins in the mouse proteome with the greatest association to the 28 modulated proteins. This analysis pinpointed a significant alteration of the proteasome function, since top scoring proteins were related to the proteasome system (PS), a protein complex involved in ATP-dependent protein degradation. In this regard, we observed that THC decreases 20S proteasome chymotrypsin-like protease activity in the hippocampus. Our data describe for the first time the modulation of the PS in the hippocampus following THC administration under amnesic conditions that may contribute to an aberrant plasticity at synapses., This study was supported by Grants from the Ministerio de Economía, Innovación y Competitividad (MINECO) (#BFU2015-68568-P (MINECO/FEDER, UE) to A.O., #BFU2015-69717-P (MINECO/FEDER, UE) to RRV and AB, #RYC-2011-08391 to AB, #SAF2017-90664-REDT to RRV and AB, #SAF2014-59648-P and #SAF2017-84060-R to R.M.; a grant from the Instituto de Salud Carlos III (#RD16/0017/0020) to R.M.; Generalitat de Catalunya (2017SGR-669 to R.M. and 2017SGR1776 to RRV and AB) and ICREA (Institució Catalana de Recerca i Estudis Avançats) Academia to A.O. and R.M. Mass spectrometric analyses were performed at the CRG/UPF Proteomics Unit which is part of the of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I + D + i 2013-2016, funded by ISCIII and ERDF. Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO (#MDM-2014-0370); PLAN E (Plan Español para el Estímulo de la Economía y el Empleo); FEDER funding is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Contreras-Rodríguez, Oren
  • Burokas, Aurelijus
  • Ortega Sánchez, Juan Antonio
  • Blasco Solà, Gerard
  • Coll, Claudia
  • Biarnés, Carles
  • Castells Nobau, Anna
  • Puig, Josep
  • Garre Olmo, Josep
  • Ramos, Rafel
  • Pedraza, Salvador
  • Brugada, Ramon
  • Vilanova, Joan Carles
  • Serena, Joaquín
  • Barretina Ginesta, Jordi
  • Gich Fullà, Jordi
  • Pérez Brocal, Vicente
  • Moya, Andrés
  • Fernández Real, Xavier
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Sol, Joaquim
  • Jové Font, Mariona
  • Ricart, Wifredo
  • Portero Otín, Manuel
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Background Inhibitory control (IC) is critical to keep long-term goals in everyday life. Bidirectional relationships between IC deficits and obesity are behind unhealthy eating and physical exercise habits. Methods We studied gut microbiome composition and functionality, and plasma and faecal metabolomics in association with cognitive tests evaluating inhibitory control (Stroop test) and brain structure in a discovery (n=156), both cross-sectionally and longitudinally, and in an independent replication cohort (n=970). Faecal microbiota transplantation (FMT) in mice evaluated the impact on reversal learning and medial prefrontal cortex (mPFC) transcriptomics. Results An interplay among IC, brain structure (in humans) and mPFC transcriptomics (in mice), plasma/faecal metabolomics and the gut metagenome was found. Obesity-dependent alterations in one-carbon metabolism, tryptophan and histidine pathways were associated with IC in the two independent cohorts. Bacterial functions linked to one-carbon metabolism (thyX,dut, exodeoxyribonuclease V), and the anterior cingulate cortex volume were associated with IC, cross-sectionally and longitudinally. FMT from individuals with obesity led to alterations in mice reversal learning. In an independent FMT experiment, human donor’s bacterial functions related to IC deficits were associated with mPFC expression of one-carbon metabolism-related genes of recipient’s mice. Conclusion These results highlight the importance of targeting obesity-related impulsive behaviour through the induction of gut microbiota shifts., This work was partially supported by research grants FIS (PI15/01934 and PI18/01022) from the Instituto de Salud Carlos III from Spain, SAF2015- 65878-R and #AEI-SAF2017-84060-R-FEDER from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain; and also by Fondo Europeo de Desarrollo Regional (FEDER) funds, European Commission (FP7, NeuroPain #2013-602891), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2015), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020), the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), the Catalan Goverment (Agency for Management of University and Research Grants [2017SGR696] and Department of Health [STL002/16/00250]; the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT); and the Project ThinkGut (EFA345/19) 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A SpainFrance-Andorra programme (POCTEFA 2014-2020). MA-R is funded by a predoctoral Río Hortega contract from the Instituto de Salud Carlos III (ISCIII, CM19/00190), co-funded by the European Social Fund “Investing in your future”. OC-R is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP20/00165), co-funded by the Europeran Social Fund "Investing in your future". JM-P is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund “Investing in your future”. JS is funded by a predoctoral PERIS contract (SLT002/16/00250) from the Catalan Government. MJ is a professor under the “Serra Hunter” programme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions

  • Blanch-Rubió, Josep
  • Soldevila-Domenech, Natalia
  • Tío, Laura
  • Llorente Onaindia, Jone
  • Ciria Recasens, Manuel
  • Polino, Luciano
  • Gurt, Alba
  • Torre Fornell, Rafael de la
  • Maldonado, Rafael, 1961-
  • Monfort, Jordi
  • The Covidmar Study Group
Coronavirus disease 19 (COVID-19) is currently a global pandemic that affects patients with other pathologies. Here, we investigated the influence of treatments for osteoporosis and other non-inflammatory rheumatic conditions, such as osteoarthritis and fibromyalgia, on COVID-19 incidence. To this end, we conducted a cross-sectional study of 2,102 patients being treated at the Rheumatology Service of Hospital del Mar (Barcelona, Spain). In our cohort, COVID-19 cumulative incidence from March 1 to May 3, 2020 was compared to population estimates for the same city. We used Poisson regression models to determine the adjusted relative risk ratios for COVID-19 associated with different treatments and comorbidities. Denosumab, zoledronate and calcium were negatively associated with COVID-19 incidence. Some analgesics, particularly pregabalin and most of the studied antidepressants, were positively associated with COVID-19 incidence, whereas duloxetine presented a negative association. Oral bisphosphonates, vitamin D, thiazide diuretics, anti-hypertensive drugs and chronic non-steroidal anti-inflammatory drugs had no effect on COVID-19 incidence in the studied population. Our results provide novel evidence to support the maintenance of the main anti-osteoporosis treatments in COVID-19 patients, which may be of particular relevance to elderly patients affected by the SARS-CoV-2 pandemic., This study was supported by Hospital del Mar. Authors funding includes “Ministerio de Ciencia, Innovación y Universidades” (#AEI-SAF2017-84060-R FEDER to R.M., #DPI2016-80283-C2-2-R), “Ministerio de Sanidad, Servicios Sociales e Igualdad” (#RD16/0017/0020 & #PNSD-2017I068 to R.M., #PI18/00059 to TCS-M) and “Generalitat de Catalunya” (#2017-SGR-669 & #ICREA- Acadèmia 2015 to R.M., #2017-SGR-138 to R.D.L.T.). N.S.D. is recipient of predoctoral fellowship #2019-DI-47 from the DIUE-AGAUR of the “Generalitat de Catalunya”.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome

  • Navarro-Romero, Alba
  • Vázquez-Oliver, Anna
  • Gomis González, Maria, 1988-
  • Garzón-Montesinos, Carlos
  • Falcón-Moya, Rafael
  • Pastor, Antonio
  • Martín García, Elena, 1975-
  • Pizarro Lozano, Mª Nieves
  • Busquets Garcia, Arnau, 1985-
  • Revest, Jean-Michel
  • Piazza, Pier Vincenzo
  • Bosch, Fatima
  • Dierssen, Mara
  • Torre Fornell, Rafael de la
  • Rodríguez-Moreno, Antonio
  • Maldonado, Rafael, 1961-
  • Ozaita Mintegui, Andrés, 1969-
Intellectual disability is the most limiting hallmark of Down syndrome, for which there is no gold-standard clinical treatment yet. The endocannabinoid system is a widespread neuromodulatory system involved in multiple functions including learning and memory processes. Alterations of this system contribute to the pathogenesis of several neurological and neurodevelopmental disorders. However, the involvement of the endocannabinoid system in the pathogenesis of Down syndrome has not been explored before. We used the best-characterized preclinical model of Down syndrome, the segmentally trisomic Ts65Dn model. In male Ts65Dn mice, cannabinoid type-1 receptor (CB1R) expression was enhanced and its function increased in hippocampal excitatory terminals. Knockdown of CB1R in the hippocampus of male Ts65Dn mice restored hippocampal-dependent memory. Concomitant with this result, pharmacological inhibition of CB1R restored memory deficits, hippocampal synaptic plasticity and adult neurogenesis in the subgranular zone of the dentate gyrus. Notably, the blockade of CB1R also normalized hippocampal-dependent memory in female Ts65Dn mice. To further investigate the mechanisms involved, we used a second transgenic mouse model overexpressing a single gene candidate for Down syndrome cognitive phenotypes, the dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A). CB1R pharmacological blockade similarly improved cognitive performance, synaptic plasticity and neurogenesis in transgenic male Dyrk1A mice. Our results identify CB1R as a novel druggable target potentially relevant for the improvement of cognitive deficits associated with Down syndrome., A.N.-R. is the recipient of a predoctoral fellowship (Ministerio de Educación y Cultura, Spain). A.V.-O. is the recipient of a predoctoral fellowship from Jérôme Lejeune Foundation, France (Spanish Delegation). M.G.-G. was partially supported by FRAXA Research Foundation, United States. A.B-G. was the recipient of a predoctoral fellowship (Ministerio de Educación y Cultura). This study was supported by Jérôme Lejeune Foundation (French Delegation) to A.O.; Instituto de Salud Carlos III, Spain (#RD16/0017/0020) to R.M.; Ministerio de Economía, Innovación y Competitividad (MINECO), Spain (#BFU2015-68568-P to A.O., #SAF2014-59648-P and #SAF2017- 84060-R to R.M.; SAF2016-79956-R to M.D.); Catalan Foundation ‘La Marató de TV3’, Spain (#2016/20-30) to E.M.-G.; Junta de Andalucía, Spain (CVI-7290 to A.R.-M.); Generalitat de Catalunya, Spain (2014SGR-1547 and 2017SGR-669 to R.M.; 2014SGR-1125 to M.D.) and ICREA (Institució Catalana de Recerca i Estudis Avançats, Spain) Academia to A.O. and R.M. Grant “Unidad de Excelencia María de Maeztu”, funded by the MINECO (#MDM-2014-0370); PLAN E, Spain (Plan Español para el Estímulo de la Economía y el Empleo); FEDER, European Commission funding is also acknowledged
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Vulnerability to addiction

  • Maldonado, Rafael, 1961-
  • Calvé Pérez, Pablo, 1993-
  • García Blanco, Alejandra
  • Domingo Rodriguez, Laura, 1992-
  • Senabre, Eric
  • Martín García, Elena, 1975-
Addiction is a chronic brain disease that has dramatic health and socioeconomic consequences worldwide. Multiple approaches have been used for decades to clarify the neurobiological basis of this disease and to identify novel potential treatments. This review summarizes the main brain networks involved in the vulnerability to addiction and specific innovative technological approaches to investigate these neural circuits. First, the evolution of the definition of addiction across the Diagnostic and Statistical Manual of Mental Disorders (DSM) is revised. We next discuss several innovative experimental techniques that, combined with behavioral approaches, have allowed recent critical advances in understanding the neural circuits involved in addiction, including DREADDs, calcium imaging, and electrophysiology. All these techniques have been used to investigate specific neural circuits involved in vulnerability to addiction and have been extremely useful to clarify the neurobiological basis of each specific component of the addictive process. These novel tools targeting specific brain regions are of great interest to further understand the different aspects of this complex disease. This article is part of the special issue on 'Vulnerabilities to Substance Abuse.'., This work was supported by the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017-SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan NAcional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) and Plan NAcional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2019I006) to E.M-G. Figures are created with BioRender.com.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Protective role of neuronal and lymphoid cannabinoid CB 2 receptors in neuropathic pain

  • Cabañero Ferri, David
  • Ramírez-López, Angela
  • Drews, Eva
  • Schmöle, Anne
  • Otte, David M.
  • Wawrzczak-Bargiela, Agnieszka
  • Huerga Encabo, Hector, 1989-
  • Kummer, Sami, 1985-
  • Ferrer-Montiel, Antonio
  • Przewlocki, Ryszard
  • Zimmer, Andreas
  • Maldonado, Rafael, 1961-
Cannabinoid CB2 receptor (CB2) agonists are potential analgesics void of psychotropic effects. Peripheral immune cells, neurons and glia express CB2; however, the involvement of CB2 from these cells in neuropathic pain remains unresolved. We explored spontaneous neuropathic pain through on-demand self-administration of the selective CB2 agonist JWH133 in wild-type and knockout mice lacking CB2 in neurons, monocytes or constitutively. Operant self-administration reflected drug-taking to alleviate spontaneous pain, nociceptive and affective manifestations. While constitutive deletion of CB2 disrupted JWH133-taking behavior, this behavior was not modified in monocyte-specific CB2 knockouts and was increased in mice defective in neuronal CB2 knockouts suggestive of increased spontaneous pain. Interestingly, CB2-positive lymphocytes infiltrated the injured nerve and possible CB2transfer from immune cells to neurons was found. Lymphocyte CB2depletion also exacerbated JWH133 self-administration and inhibited antinociception. This work identifies a simultaneous activity of neuronal and lymphoid CB2that protects against spontaneous and evoked neuropathic pain., This paper was supported by the following grants: European Commission NeuroPain, FP7-602891-2 to Rafael Maldonado. Instituto de Salud Carlos III RTA, RD16/0017/0020/FEDER to Rafael Maldonado. Ministerio de Ciencia, Innovación y Universidades SAF2017-84060-R FEDER to Rafael Maldonado. Generalitat de Catalunya SGR2017-669, ICREA Academia Award 2015 to Rafael Maldonado. Generalitat de Catalunya 2018 FI_B 00207 to Angela Ramírez-López. Polish Ministry of Science and Education 3070/7.PR/2014/2 to Ryszard Przewlocki. Spanish Ministry of Science, Innovation and Universities 2018-097189-B-C21 to Antonio Ferrer-Montiel. Universidad Miguel Hernandez UMH-PAR2019 to Antonio Ferrer-Montiel.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior

  • Navandar, Mohit
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
  • Lutz, Beat
  • Gerber, Susanne
  • Ruiz de Azua, Iñigo
Addiction is a chronic relapsing brain disease characterized by compulsive reward-seeking despite harmful consequences. The mechanisms underlying addiction are orchestrated by transcriptional reprogramming in the reward system of vulnerable subjects. This study aims at revealing gene expression alterations across different types of addiction. We analyzed publicly available transcriptome datasets of the prefrontal cortex (PFC) from a palatable food and a cocaine addiction study. We found 56 common genes upregulated in the PFC of addicted mice in these two studies, whereas most of the differentially expressed genes were exclusively linked to either palatable food or cocaine addiction. Gene ontology analysis of shared genes revealed that these genes contribute to learning and memory, dopaminergic synaptic transmission, and histone phosphorylation. Network analysis of shared genes revealed a protein-protein interaction node among the G protein-coupled receptors (Drd2, Drd1, Adora2a, Gpr6, Gpr88) and downstream targets of the cAMP signaling pathway (Ppp1rb1, Rgs9, Pde10a) as a core network in addiction. Upon extending the analysis to a cell-type specific level, some of these common molecular players were selectively expressed in excitatory neurons, oligodendrocytes, and endothelial cells. Overall, computational analysis of publicly available whole transcriptome datasets provides new insights into the molecular basis of addiction-like behaviors in PFC., We thank the financial support of the Spanish “Ministerio de Ciencia, Innovación y Universidades” (#AEI-SAF2017-84060-R FEDER), the “Instituto de Salud Carlos III” (#RD16/0017/0020), the “Plan Nacional Sobre Drogas” of the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad” (#RD16/0017/0020 & #PNSD-2017I068) and the AGAUR of the “Generalitat de Catalunya” (#2017-SGR-669 and #ICREA-Acadèmia 2015) to R.M. and Fundació La Marató-TV3 (#2016/20-30) and Plan Nacional Sobre Drogas (#PNSD-2019I006) to E.M.G.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

  • Domingo Rodriguez, Laura, 1992-
  • Ruiz de Azua, Iñigo
  • Domínguez, Eduardo
  • Senabre, Eric
  • Serra, Irene
  • Kummer, Sami, 1985-
  • Navandar, Mohit
  • Baddenhausen, Sarah
  • Hofmann, Clementine
  • Andero, Raül
  • Gerber, Susanne
  • Navarrete, Marta
  • Dierssen, Mara
  • Lutz, Beat
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Food addiction is linked to obesity and eating disorders and is characterized by a loss of behavioral control and compulsive food intake. Here, using a food addiction mouse model, we report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic neurons prevents the development of food addiction-like behavior, which is associated with enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological mechanism underlying resilience and vulnerability to the development of food addiction, which could pave the way towards novel and efficient interventions for this disorder., This work was supported by the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD-2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) to E.M-G., the German Research Foundation (#CRC1193 “Neurobiology of Resilience”, TP A05 and B04) to B.L. and S.G., and the Boehringer Ingelheim Foundation to B.L., S.G. and I.R.A. The work of M.N.A was supported by the Emergent AI Center funded by the Carl-Zeiss-Stiftung. NARSAD Young Investigator Award (#22434), MINECO Ramón y Cajal (#RYC- 2014-15784) and (#SAF2016-76565-R) and Fondo Europeo de Desarrollo Regional (FEDER) to R.A. DIUE Generalitat de Catalunya (#2017 SGR 595), MINECO (#SAF2016-79956-R), EU (#Era Net Neuron PCIN-2013-060), Fundació La Marató-TV3 (#2016/20-31), CRG acknowledges support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Center of Excellence Severo Ochoa (#SEV-2012-0208), the CERCA Programme/Generalitat de Catalunya, the CIBER of Rare Diseases of the ISCIII to M.D. MINECO Ramón y Cajal (#RYC-2016-20414), AGAUR (#2017 SGR 926), (#RTI2018-094887-B-I00) and Fondo Europeo de Desarrollo Regional (FEDER) to M.N.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

  • Domingo-Rodriguez, Laura|||0000-0003-3286-6696
  • Ruiz de Azua, Inigo
  • Dominguez, Eduardo
  • Senabre, Eric|||0000-0001-8507-8154
  • Serra, Irene
  • Kummer, Sami
  • Navandar, Mohit
  • Baddenhausen, Sarah|||0000-0001-9847-6960
  • Hofmann, Clementine
  • Andero Galí, Raül|||0000-0003-3641-8903
  • Gerber, Susanne
  • Navarrete, Marta|||0000-0003-2097-4788
  • Dierssen, Mara|||0000-0003-0853-6865
  • Lutz, Beat|||0000-0002-1062-6889
  • Martín-García, Elena|||0000-0002-4487-3028
  • Maldonado, Rafael|||0000-0002-4359-8773
Food addiction is linked to obesity and eating disorders and is characterized by a loss of behavioral control and compulsive food intake. Here, using a food addiction mouse model, we report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic neurons prevents the development of food addiction-like behavior, which is associated with enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological mechanism underlying resilience and vulnerability to the development of food addiction, which could pave the way towards novel and efficient interventions for this disorder. Food addiction is linked to obesity and eating disorders. In a mouse model of food addiction, the authors show that a medial prefrontal cortex-nucleus accumbens pathway is involved in vulnerability and resilience against the development of food addiction-like behavior.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

  • Navarro-Romero, Alba
  • Galera-López, Lorena
  • Ortiz-Romero, Paula|||0000-0002-6378-6763
  • Llorente-Ovejero, Alberto
  • de los Reyes-Ramírez, Lucía
  • Bengoetxea de Tena, Iker
  • Garcia-Elias, Anna|||0000-0002-6609-6119
  • Mas-Stachurska, Aleksandra|||0000-0003-4947-4111
  • Reixachs-Solé, Marina
  • Pastor, Antoni|||0000-0003-3692-0696
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Eyras, Eduardo|||0000-0003-0793-6218
  • Rodríguez-Puertas, Rafael|||0000-0003-4517-5114
  • Campuzano, Victoria|||0000-0001-8128-2641
  • Ozaita, Andres|||0000-0002-2239-7403
Williams-Beuren syndrome (WBS) is a rare genetic multisystemic disorder characterized by mild-to-moderate intellectual disability and hypersocial phenotype, while the most life-threatening features are cardiovascular abnormalities. Nowadays, there are no pharmacological treatments to directly ameliorate the main traits of WBS. The endocannabinoid system (ECS), given its relevance for both cognitive and cardiovascular function, could be a potential druggable target in this syndrome. We analyzed the components of the ECS in the complete deletion (CD) mouse model of WBS and assessed the impact of its pharmacological modulation in key phenotypes relevant for WBS. CD mice showed the characteristic hypersociable phenotype with no preference for social novelty and poor short-term object-recognition performance. Brain cannabinoid type-1 receptor (CB1R) in CD male mice showed alterations in density and coupling with no detectable change in main endocannabinoids. Endocannabinoid signaling modulation with subchronic (10 days) JZL184, a selective inhibitor of monoacylglycerol lipase, specifically normalized the social and cognitive phenotype of CD mice. Notably, JZL184 treatment improved cardiovascular function and restored gene expression patterns in cardiac tissue. These results reveal the modulation of the ECS as a promising novel therapeutic approach to improve key phenotypic alterations in WBS. Williams-Beuren syndrome (WBS) is a rare disorder that causes hyper-social behavior, intellectual disability, memory problems, and life-threatening overgrowth of the heart. Behavioral therapies can help improve the cognitive and social aspects of the syndrome and surgery is sometimes used to treat the effects on the heart, although often with limited success. However, there are currently no medications available to treat WBS. The endocannabinoid system - which consists of cannabis-like chemical messengers that bind to specific cannabinoid receptor proteins - has been shown to influence cognitive and social behaviors, as well as certain functions of the heart. This has led scientists to suspect that the endocannabinoid system may play a role in WBS, and drugs modifying this network of chemical messengers could help treat the rare condition. To investigate, Navarro-Romero, Galera-López et al. studied mice which had the same genetic deletion found in patients with WBS. Similar to humans, the male mice displayed hyper-social behaviors, had memory deficits and enlarged hearts. Navarro-Romero, Galera-López et al. found that these mutant mice also had differences in the function of the receptor protein cannabinoid type-1 (CB1). The genetically modified mice were then treated with an experimental drug called JZL184 that blocks the breakdown of endocannabinoids which bind to the CB1 receptor. This normalized the number and function of receptors in the brains of the WBS mice, and reduced their social and memory symptoms. The treatment also restored the animals' heart cells to a more normal size, improved the function of their heart tissue, and led to lower blood pressure. Further experiments revealed that the drug caused the mutant mice to activate many genes in their heart muscle cells to the same level as normal, healthy mice. These findings suggest that JZL184 or other drugs targeting the endocannabinoid system may help ease the symptoms associated with WBS. More studies are needed to test the drug's effectiveness in humans with this syndrome. Furthermore, the dramatic effect JZL184 has on the heart suggests that it might also help treat high blood pressure or conditions that cause the overgrowth of heart cells.